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Abstract: The reactions of dialkyl acetylenedicarboxylates with various 2-oxo-acenaphthoquinylidene-
and 4-acetyl[2.2]paracyclophanylidene-thiosemicarbazones were investigated. Using simple
experimental procedures, 1,3-Thiazolidin-4-ones derived from acenaphthequinone or
[2.2]paracyclophane were obtained as major products in good yields. In the case of allyl
derivative of acenaphthoquinylidene-thiosemicarbazones, a complex structure of tetramethyl
5-(2-(((Z,E)-N-allyl-N′-(2-oxoacenaphthylen-1(2H)-ylidene)carbamohydrazonoyl)thio)-1,2,3-tris-
(methoxycarbonyl)-cyclopropyl)-4-methoxy-7-oxabicyclo[2.2.1]hepta-2,5-diene-1,2,3,6-tetracarboxylate
was formed. Single crystal X-ray analysis was used as an efficient tool to confirm the structure of the
synthesized compounds as well as different spectroscopic data (1H-NMR, 13C-NMR, 2D-NMR, mass
spectrometry and elemental analysis). The mechanism of the obtained products was discussed.
Keywords: acenaphthequinone; 4-acetyl[2.2]paracyclophane; thiosemicarbazone; dialkyl-
acetylenedicarboxylates; 1,3-thiazolidinones; DMAD tetramer
1. Introduction
Of interest due to their high biological activities, 1,3-Thiazolidin-4-one derivatives are very
important core structures of many heterocyclic compounds. Compounds with a thiazolidinone structure
have been reported as anti-inflammatory and analgesic [1], antioxidants [2], antitubercular [1,3],
antimicrobial [2,4] and antifungal [4], antiviral (especially as anti-HIV agents [5]), anticancer [1],
anticonvulsants [6], and antidiabetic agents [6,7]. Recently, various synthetic routes were used for the
synthesis of different thiazolidinones from several thiosemicarbazides and thiocarbohydrazides by using
different reagents, and their biological evaluation was also discussed [8,9]. Thiosemicarbazones were
used as a starting material for the synthesis of different heterocyclic compounds, i.e., naphtho-thiazole
and naphtho-thiadiazepines [10], 4-thiazolidinone derivatives [11,12], 1,3,4-thiadiazoles [13] which
possess high biological activities, e.g., anticancer [14], antioxidants [15], antifungal [16], and
antibacterial [17].
Acenaphthequinone (acenaphthylene-1,2-dione) is a quinone derivative, widely used as significant
starting material for the synthesis of various heterocycles, and as a key intermediate in organic synthesis
for different reactions and pharmaceutical applications [18–21]. Some derivatives of acenaphthequinone
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have been used as biological active compounds, dyes, pharmaceuticals, drugs, pesticides, and
therapeutic agents [22–24]. Acenaphthylene-1,2-dione is one of the important reagents for constructing
new heterocycles, e.g., spirooxadiazoline [25], spiroacenaphthyl-3,4′-pyranopyrazoles [26], fused
acenaphthopyrrolizines and spiroacenaphthene pyrrole [27], dispiropyrrolidines [28,29], and polycyclic
heterocycles [29,30] via reactions such as the Huisgen reaction, 1,3-dipolar cycloaddition, and
[3+2]cycloaddition reactions. One pot synthesis of 2-oxo-1,2-dihydroacenaphthylphosphonates
was obtained by using a Knoevenagel-phospha-Michael reaction of acenaphthequinone, malononitrile,
and diethylphosphite catalyzed by a 1,4-diazabicyclo-[2.2.2]octane (DABCO)-based ionic liquid [31].
Recently, three component reactions were widely used as one of the most efficient routes for the
synthesis of many heterocyclic rings. Consequently, three component reactions of acenaphthequinone,
proline derivatives and dialkyl acetylenedicarboxylates gave azocinobenzoisoquinolone-dicarboxylates
through [3+2]cycloaddition of azomethine ylides followed by ring expansion [32]. In addition, the
domino three component reaction of isoquinolinium salts, acenaphthequinone and indanedione in
basic media yielded 2′-acenaphthylidenespiro[indane-2,1′-pyrrolo[2,1-a]isoquinolones] [33]. Using
a similar synthetic strategy, bis-spiro-oxoacenaphthalenes were obtained via the reaction of
acenaphthalene-1,2-dione, active alkynes, and 4-cyanopyridine in 1,2-dimethoxyethane (DME) at
room temperature [34]. The reaction of dialkyl acetylenedicarboxylate with acenaphthalenedione and
CS2 in t-butylphosphine afforded oxoindolin-3-ylidene-1,3-dithioles [35]. Also, spirodihydropyridine
derivatives were obtained in high yields from the reaction of acenaphthylidene malononitrile and
Zwitter ionic intermediate (generated from primary amine and dimethyl acetylenedicarboxylate
(DMAD) [36].
Since the maturation of the synthetic methodologies, with the possibilities for the fine-tuning of
structural and functional properties, [2.2]paracyclophane (PC) chemistry has evolved—from functional
molecules to functional materials [37]—and is rapidly growing from a structural and synthetic
curiosity to a prevalent scaffold in asymmetric synthesis [37], pi-stacked polymers, energy materials,
and functional perylene coatings that find broad applications in bio-material science and as natural
products [38–40]. Aly et al. prepared various heterocycles derived from [2.2]paracyclophane such as a
five-membered ring (i.e., imidazolone and pyrrole [41–44] and six-membered ring (i.e., pyridine [45]).
Additionally, we reported on the synthesis of various paracyclophanyl-substituted thiosemicarbazones,
thiocarbazones and thioureas then studied their complexation towards tridentate and bidentate copper
complexes [46]. Inspired by the aforementioned, we aim here to synthesize various thiazolidinone
derivatives of both acenaphthequinone and [2.2]paracyclophane.
2. Results and Discussion
Acenaphthequinones conjugated with NH, SH, CH=N and NH2 groups are of considerable
interest in organic synthesis and were produced from the condensation of thiosemicarbazide
and 4-substituted thiosemicarbazides with acenaphthylene-1,2-dione [47]. A literature survey
revealed, that acenaphthequinone (1) was reacted with thiosemicarbazide 2a either in ethanol at
room temperature and catalyzed by acidic ionic liquid furnished spiro-1,2,4-triazolidine-3-thiones
3a [48] or in refluxing chloroform in the presence of glacial acetic acid (AcOH) yielded
acenaphtho[1,2-e]-1,2,4-triazine-9(8H)-thione 4 (Scheme 1) [49].
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2.1. Preparation of Compounds 5a–e
It was obvious that the reaction conditions, e.g., solvent, temperature and/or catalyst
play a vital role on the reaction efficiency and product obtained. Various conditions were
investigated and the most efficient method was the condensation of thiosemicarbazide
derivatives with acenaphthalene-1,2-dione in refluxing ethanol in the presence of Et3N to give
(Z)-N-unsubstituted/substituted-2-(2-oxoacenaphthylen-1(2H)-ylidene)hydrazinecarbothioamide
derivatives (Scheme 2) instead of the aforementioned spiro-1,2,4-triazolidine-3-thione
(3a) [48] and 1,2,4-triazine-3-thione 4 [49]. Although (Z)-2-(2-oxoacenaphthylen-1(2H)-ylidene)
hydrazinecarbothioamide 5a was previously reported [50], its structure was confirmed herein using single
crystal X-ray analysis (Figure 1).
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2.2. eaction of o pounds 5a–e ith i ethyl cetylenedicarboxylate ( , 6)
mixture of dimethyl acetylenedicarboxylate ( MAD, 6a) and (Z)-N-unsubstituted/
substituted-2-(2-oxoacenaphthylen-1-(2H)-ylidene)thiosemicarbazones 5a–e, was refluxed in absolute
EtOH for 20–30 min. The reaction revealed the complete disappearance of compounds 5a–e an 6a to
give compounds 7a–e in 70–76% yields (Scheme 3). Surprisingly, only in the case of allyl derivative 5d,
an unexpected compound 8d was obtained in 10% yield (Scheme 3). Different spectroscopic data were
insufficient to etermine completely the correct structure of this compound.
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4-thiazolidinones 7a–e and/or 12a–e via the loss of methanol (Scheme 4). The 1H and 13C-NMR spectral
data (see details in Supplementary Materials) were used as an important tool for excluding some
alternative structures. Furthermore, in the case of 7a–e and 12a–e, X-ray analyses were used as a useful
tool to determine the correct structure and to prove that the 1,3-thiazolidine-4-ones 7a–e were formed
rather than 12a–e.
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Table 1. NMR spectroscopic data of 7a.
1H-NMR: 1H-1H COSY: Assignment:
13.46 (b; 1H) NH-3′
8.35 (d, J = 8.2; 1H) 7.86 H-5
8.20 (d, J = 8.2; 1H) 7.85 H-6
8.01 (d, J = 7.8; 1H) 7.86 H-3
7.99 (d, J = 7.0; 1H) 7.85 H-8
7.86 (“t”, J = 7.9; 1H)8.35, 8.01 H-4
7.85 (“t”, J = 8.0; 1H) 8.20, 7.99 H-7
6.73 (s; 1H) H-5a′
3.81 (s; 3H) H-5c′
13C NMR: 1H-13C HSQC: H-13C HMBC: Assignment:
183.77 8.01, 7.86 C-2
166.01 C-4
165.78 6.73, 3.81 C-5′
154.23 C-2′
151.66 7.99 C-1
142.07 6.73 C-5′
139.71 8.35, 8.20, 8.01, 7.86, 7.85 C-9a
131.86 8.35 8.20, 8.01, 7.86 C-5
131.15, 131.05, 130.06 8.35, 8.20, 8.01, 7.86, 7.85 C-2a, 5a, 9
128.95, 128.59 7.86, 7.85 8.35, 7.99 C-4, 7
128.20 8.20 8.20 C-6
121.52 8.01 8.35 C-3
118.82 7.99 8.20 C-8
115.27 6.73 6.73, 3.81 C-5a′
52.49 3.81 3.81 C-5c′
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Figure 2. The distinctive carbons in co pound 7a.
Additionally, the structure of (Z)-methyl 2-((Z)-3-allyl-4-oxo-2-((E)-(2-oxoacenaphthylen-1(2H)-
ylidene)hydrazono)thiazolidin-5-ylidene)acetate (7d) has been unambiguously confirmed via a
single-crystal X-ray structure analysis (Figure 3). The characteristic properties of compound 7d
are that the C2-N13 and C15-N14, double bonds (note that the crystallographic numbering does not
correspond to the systematic IUPAC numbering rules) exhibit bond lengths of 1.2912 (16) Å and 1.2892
(16) Å, respectively, that are a little shorter than C = N δ bonds due to high resonance in 7d. The
dihedral angle of N19-C15-N14-N13 is 178.82 (9)◦, showing that it has a trans configuration relating to
N19. Bond lengths C1-C2 and N13-N14 are 1.5345 (16) and 1.3950 (14), respectively, which are shorter
than the corresponding C-C and N-N single bonds due to high resonance in this compound. From
X-ray analysis, it was also observed that the thiazolidine C = O has a cisoid geometry regarding to
vinyl CH [torsion angle O18–C18–C17–C23 −2.2 (2)◦].
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A literature survey revealed that, the tetra erization reaction is one of the most fascinating
reactions of both dialkyl acetylenedicarboxylic acid derivatives occurring at 25 ◦C for several days or
by heating it alone or in solution for several hours [51–53]. Furthermore, trimer [54] and dimer [55]
forms were reported for compound 6a. Recently, Huang et al. [56] have reported the reaction of
2,2′-bis(azaphosphindole) with four equivalents of 6a in THF at room temperature to afford a tetramer
complex of 6a with 2,2′-bis(azaphosphindole).
The structure of 8d was resolved by using single crystal X-ray analysis and it was found that
it is tetramethyl 5-(2-(((Z,E)-N-allyl-N′-(2-oxoacenaphthylen-1(2H)-ylidene)carbamo-hydrazonoyl)
-thio)-1,2,3-tris(methoxycarbonyl)cyclopropyl)-4-methoxy-7-oxabicyclo-[2.2.1]hepta-2,5-diene-1,2,3,6-
tetracarboxylate (8d) (Figure 4). To our best knowledge, it would be the first X-ray structure of that
tetramer of 6a. It is interesting to note that only one diastereomer was isolated (at least being isolated).
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The unusual reactivity of 6a towards allyl derivative of thiosemicarbazones 5d obviously involves
four molecules of 6 reacting with one molecule of 5d. The mechanism presumably begins via
dimerization of 6a (acting as dienophile and as 1,3-dipole) to afford 13, which then rearranged to give
14. Addition of the third molecule of 6a to the intermediate 14 would give the intermediate 15, which
would be neutralized to give cyclopropene 16 (Scheme 5). Diels-Alder reaction of 16 and the fourth
molecule of 6a, yield the complex 17 [56] (Scheme 5). Subsequently, a nucleophilic attack of thione-lone
pair of thiosemicarbazone 5d to the double bond of the cyclopropene ring would give the Zwitter ion
18, which would be neutralized to give compound 8d (Scheme 5).
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The for ation of a co plex structure ay be further used as a Supple entary tool for the
for ation of 1,3-thiazolidinone derivative 7d, which might be attributed to the instability of 8d during
the course of a reaction. It can be also suggested that another nucleophilic attack of NH lone-pair of
compound 8d to one of the carbonyl ester group of the cyclopropane ring afforded the intermediate 19
that would be rearranged giving the 4-thiazolidinone 7d and 20 (Scheme 6). However, compound 20
was unfortunately not isolated.
On the other hand, the synthesis of 4-acetyl[2.2]paracyclophanylidene thiose icarbazone (22a)
as established from the reaction between 4-acetyl[2.2]paracyclophane (21) and thiosemicarbazide (2a)
and by applying the procedure described by Aly et al. [46].
Si ilarly, the reaction of 21 with 2f gave 22f in 60% yield (Scheme 7). If
two equivalents of 21 were reacted with one equivalent of thiocarbohydrazide (2f), the
reaction gave bis-4-acetyl-[2.2]paracyclophanylidene-hydrazine-1-carbothiohydrazone (23) in 88%
yield. In addition, refluxing of the two equivalents of N-cyclohexylhydrazinecarbothioamide
(2c) with 4,15-diformyl-2.2]paracyclophane (24) yielded the desired 2,2′-(1,4(1,4)-dibenzen-
acyclohexaphane-12,43-diylbis(methane-ylylidene))bis-(N-cyclohexylhydrazine-1-carbothioamide (25) in
80% yield (Scheme 7). The X-ray structure analysis of compound 25 is as shown in Figure 5.
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We aimed to synthesize thiazolidinones bearing a paracyclophanyl moiety; accordingly, we
reacted 4-acetyl[2.2]paracyclophanylidene-thiosemicarbazone derivatives 22a and 22f with DMAD,
6a and DEAD, 6b (Scheme 8). By adaptation of the previously mentioned procedure, the
expected 1,3-thiazolidinones 26–29 were obtained in good yields (Scheme 8). Depending on
1H-NMR and 13C-NMR, various alternative structures were ruled out. In order to distinguish
between the expected 1,3-thiazolidinone derivatives, a single crystal of 28 was obtained
as ethyl 2-((Z)-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)hydrazine-ylidene)-4-
oxothiazolidin-5-yl)acetate (Figure 6).
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3. aterial a et o s
3.1. Chemistry
Melting points (mp’s) were recorded on a Gallenkamp melting point apparatus (Gallenkamp,
UK) using open capillaries and were uncorrected. NMR data were recorded on Bruker AM 400 or
AV400 spectrometers (Bruker, Rheinstetten, Germany), at 400 MHz for 1H and 100 MHz for 13C.
Chemical shifts were reported in ppm from tetramethylsilane using solvent resonance in CDCl3 or
DMSO-d6 solutions as the internal standard. The 13C-NMR signals were assigned on the basis of DEPT
135/90 spectra. The mass spectra were obtained on Finnigan MAT 312) (Germany) instrument using
electron impact ionization (70 eV). The IR spectra were recorded on Bruker Alpha FT-IR instrument
(Germany) with samples prepared as potassium bromide pellets. Thin-layer chromatography (TLC)
was performed on precoated plates (silica gel 60 PF254), and zones were visualized with ultraviolet
(UV) light. Elemental analyses for C, H, N were carried out with Elementar 306.
3.1.1. Starting Materials: Acenaphthequinone, 1 Was Bought and Bought from Aldrich, whereas
[2.2]Paracyclophane Was Commercially Available
Preparation of 2-Oxoacenaphthylidene Thiosemicarbazones 5a–e
Compounds 5a–e were synthesized by refluxing solutions of acenaphthequinone 1 (1.82 g, 10
mmol) in absolute EtOH (100 mL) containing triethylamine (0.5 mL) and different solutions of
thiosemicarbazide derivatives 2a–e for 3–5 h. The products were left to stand, and then collected
by filtration after precipitation with ethanol. The resulting solid was recrystallized from the stated
solvents to give yellow to orange crystals.
(Z)-2-(2-Oxoacenaphthylen-1-(2H)-ylidene)hydrazinecarbothioamide (5a). Yield: (1.58 g, 70%); orange
crystals (EtOH); m.p.: 214–216 ◦C [50].
(Z)-2-(2-Oxoacenaphthylen-1-(2H)-ylidene)-N-phenylhydrazinecarbothioamide (5b). Yield: (2.65 g, 80%);
yellow crystals (MeOH); m.p.: 208–210 ◦C [47].
( )- - l l- -( -o oace aphthylen-1-(2 )-ylidene)hydrazinecarbothioamide (5c). i l : ( . , );
ll t l ( 3 ); . .: ◦ . I ( ): 3295 ( ’s), ( li- ), ( ),
( ), ( - ) 1. 1H-NMR (4 0 MHz, D SO-d6): δ = 1.17 (m, 1H, cyclic-CH), 1.33 ( , ,
li - 2), . ( , , li - 2), .66 ( , , li - ), . ( , , li - 2), . ( , ,
li - 2), . ( , 1 , cyclic-CH), 7.85 (t, 1H, Ar-H, J = 7.9 Hz), 7.89 (t, 1H, Ar-H, J = 8.1 Hz), 8.09 (d,
1H, Ar-H, J = 8.2 Hz), 8.10 (d, 1H, Ar-H, J = 8.2 Hz), 8.15 (d, 1H, Ar-H, J = 8.3 Hz), 8.38 (d, 1H, Ar-H, J
= 8.2 Hz), 8.97 (d, 1H, cyclohexyl-NH), 12.62 (s, 1H, = N-NH). 13C-NMR: (100 MHz, DMSO-d6): δ =
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24.87, 25.05, 31.44 (cyclic-CH2), 53.84 (cyclic-CH), 118.61, 122.43, 127.05, 128.54, 128.79, 132.76 (Ar-CH),
129.88, 129.99, 130.43, 139.09 (Ar-C), 137.24 (C=N), 176.04 (C=S), 188.51 (C=O). MS: m/z (%) = 387 (M+,
100), 180 (53), 154 (59), 136 (40), 107 (13). Anal. Calcd. for C19H19N3OS (337.44); C, 67.63; H, 5.68; N,
12.45; S, 9.50. Found: C, 67.55; H, 5.75; N, 12.35; S, 9.57.
(Z)-N-Allyl-2-(2-oxoacenaphthylen-1-(2H)-ylidene)hydrazinecarbothioamide (5d). Yield: (2.18 g, 74%); light
orange crystals (EtOH), m.p.: 190–191 ◦C [57].
(Z)-N-Ethyl-2-(2-oxoacenaphthylen-1(2H)-ylidene)hydrazinecarbothioamide (5e). Yield: (2.03 g, 72%); yellow
crystals (EtOH), m.p.: 195–196 ◦C; [47].
Reactions of 2-Oxoacenaphthylidene Thiosemicarbazone Derivatives with 6a
A mixture of 2-oxoacenaphthylidene thiosemicarbazones (5a–e, 1 mmol) in absolute ethanol
(50 mL) was refluxed with 6a for 20–30 min and the reaction was monitored by TLC analysis. A
yellow precipitate of 7a–e was formed, and then the reaction mixture was filtered and washed with
a small amount of ethanol. The obtained precipitates were crystalized in ethanol to give yellow
crystals of 1,3-thiazolidin-4-ones 7a–d. In addition, the filtrate was left to stand at room temperature
after separation of the precipitates 7a–e and, in the case of 7d, fine crystals of 8d were collected after
filtration).
(Z)-Methyl 2-((Z)-4-oxo-2-((E)-(2-oxoacenaphthylen-1-(2H)-ylidene)hydrazono)thiazolidin-5-ylidene)acetate
(7a). Yield: (0.277 g, 76%); yellow crystals (EtOH); m.p.: 252–254 ◦C. IR (KBr): ν = 3489 (NH), 3150
(Ar-CH), 2960 (Ali-CH), 1715, 1696 (CO), 1623 (C=N), 1604 (Ar-C=C) cm−1. NMR see Table 1. MS, m/z
(%) = 365 (M+, 10), 307 (35), 154 (100), 137 (65), 107 (17). Anal. Calcd. for C18H11N3O4S (365.36); C,
59.17; H, 3.03; N, 11.50; S, 8.78. Found: C, 59.26; H, 3.07; N, 11.57; S, 8.67.
(Z)-Methyl 2-((Z)-4-oxo-2-((E)-(2-oxoacenaphthylen-1-(2H)-ylidene)hydrazono)-3-phenyl-thiazolidin-5-
ylidene)acetate (7b). Yield: (0.321 g, 73%); yellow crystals (EtOH); m.p.: 266–268 ◦C. IR (KBr): ν = 3120
(Ar-CH), 2952 (Ali-CH), 1713, 1690 (CO), 1630 (C=N), 1589 (Ar-C=C) cm−1. 1H-NMR (400 MHz,
DMSO-d6): δ = 3.87 (s, 3H, OCH3), 6.95 (s, 1H, vinyl-CH), 7.49 (t, 1H, Ar-H, J = 7.7 Hz), 7.66 (m, 3H,
Ar-H), 7.69 (m, 2H, Ar-H), 7.72 (d, 1H, Ar-H, J = 7.0 Hz), 7.86 (t, 1H, Ar-H, J = 8.0 Hz), 8.07 (d, 1H,
Ar-H, J = 6.9 Hz), 8.13 (d, 1H, Ar-H, J = 8.3 Hz), 8.32 (d, 1H, Ar-H, J = 8.2 Hz). 13C-NMR (100 MHz,
DMSO-d6): δ = 52.72 (OCH3), 116.42 (vinyl-CH), 125.72, 127.19, 128.08, 128.21, 128.29, 128.74, 129.15,
129.20, 129.41 (Ar-CH), 130.06, 130.86, 132.14, 134.13, 140.69 (Ar-C), 140.77 (thiazole-C5), 155.55, 163.52
(thiazole-C2, C = N), 165.77 (cyclic-C = O), 167.12 (ester C = O), 188.41 (C = O). MS, m/z (%) = 441 (M+,
30), 306 (35), 180 (17), 154 (100), 136 (63), 107 (20). Anal. Calcd. for C24H15N3O4S (441.46); C, 65.30; H,
3.42; N, 9.52; S, 7.26. Found: C, 65.23; H, 3.38; N, 9.57; S, 7.37.
(Z)-Methyl 2-((Z)-3-cyclohexyl-4-oxo-2-((E)-(2-oxoacenaphthylen-1(2H)-ylidene)-hydrazono)-thiazolidin-5-
ylidene)acetate (7c). Yield: (0.322 g, 72%); yellow crystals (EtOH); m.p.: 284–286 ◦C. IR (KBr): ν =
3110 (Ar-CH), 2955 (Ali-CH), 1709, 1683 (CO), 1618 (C=N), 1591 (Ar-C=C) cm−1. 1H-NMR (400
MHz, DMSO-d6): δ = 1.35–1.37 (m, 2H, cyclic-CH2), 1.72–1.75 (m, 4H, cyclic-CH2), 1.86–1.88 (m, 4H,
cyclic-CH2), 2.32 (m, 1H, cyclic-CH), 3.83 (s, 3H, OCH3), 6.83 (s, 1H, vinyl-CH), 7.85 (t, 1H, Ar-H, J =
8.0 Hz), 7.88 (t, 1H, Ar-H, J = 7.8 Hz), 7.93 (d, 1H, Ar-H, J = 7.1 Hz), 8.05 (d, 1H, Ar-H, J = 7.8 Hz), 8.13
(d, 1H, Ar-H, J = 8.3 Hz), 8.26 (d, 1H, Ar-H, J = 8.3 Hz). 13C-NMR (100 MHz, DMSO-d6): δ = 27.61,
30.72, 35.93 (cyclic-CH2), 53.07 (OCH3), 59.92 (cyclic-CH), 116.42 (vinyl-CH), 119.03, 121.72, 128.33,
128.44, 128.92, 132.10 (Ar-CH), 131.23, 133.44, 131.93, 139.50 (Ar-C), 142.19 (thiazole-C5), 152.18, 155.56
(thiazole-C2, C=N), 166.37 (cyclic-C=O), 166.69 (ester-C=O), 183.87 (C=O). MS, m/z (%) = 447 (M+, 5),
306 (35), 154 (100) 137 (67), 107 (17). Anal. Calcd. for C24H21N3O4S (447.51); C, 64.41; H, 4.73; N, 9.39;
S, 7.17. Found: C, 64.32; H, 4.80; N, 9.34; S, 7.09.
(Z)-Methyl 2-((Z)-3-allyl-4-oxo-2-((E)-(2-oxoacenaphthylen-1-(2H)-ylidene)hydrazono)-thiazolidin-5-
ylidene)acetate (7d). Yield: (0.303 g, 75%); yellow crystals (EtOH); m.p.: 218–220 ◦C. IR (KBr): ν = 3085
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(Ar-CH), 2970 (Ali-CH), 1710, 1695 (CO), 1620 (C=N), 1609 (Ar-C=C) cm−1. 1H-NMR (400 MHz,
DMSO-d6): δ = 3.86 (s, 3H, OCH3), 4.75 (m, 2H, allyl-CH2N), 5.34 (m, 2H, allyl-CH2=), 6.06 (m, 1H,
allyl-CH=), 6.89 (s, 1H, vinyl-CH), 7.78 (t, 1H, Ar-H, J = 8.2 Hz), 7.81 (t, 1H, Ar-H, J = 7.9 Hz), 7.98 (d,
1H, Ar-H, J = 7.1 Hz), 8.04 (d, 1H, Ar-H, J = 7.8 Hz), 8.12 (d, 1H, Ar-H, J = 8.1 Hz), 8.58 (d, 1H, Ar-H, J =
8.1 Hz). 13C-NMR (100 MHz, DMSO-d6): δ = 47.72 (allyl-CH2N) 52.61 (OCH3), 115.28 (vinyl-CH),
118.58 (allyl-CH2=), 118.90, 121.62, 128.35, 128.70, 129.06, 131.91 (Ar-CH), 131.21, 131.63, 132.40, 138.9
(Ar-C), 134.85 (allyl-CH=), 142.23 (thiazole-C5), 151.91, 155.36 (thiazole-C2, C = N) 165.41 (cyclic-C=O),
166.54 (ester C=O), 183.93 (C=O). MS, m/z (%) = 405 (M+, 10), 306 (40), 289 (16), 154 (100), 137 (65), 107
(15). Anal. Calcd. for C21H15N3O4S (405.43); C, 62.21; H, 3.73; N, 10.36; S, 7.91. Found: C, 62.25; H,
3.68; N, 10.45; S, 7.97.
(Z)-Methyl 2-((Z)-3-ethyl-4-oxo-2-((E)-(2-oxoacenaphthylen-1-(2H)-ylidene)hydrazono)-thiazolidin-5-
ylidene)acetate (7e). Yield: (0.290 g, 74%); yellow crystals (EtOH); m.p.: 200–202 ◦C. IR (KBr): ν = 3143
(Ar-CH), 2944 (Ali-CH), 1714, 1698 (CO), 1607 (C=N), 1590 (Ar-C=C) cm−1. 1H-NMR (400 MHz,
DMSO-d6): δ = 1.36 (t, 3H, CH3, J = 6.72 Hz), 3.75 (q, 2H, CH2, J = 6.72 Hz), 3.82 (s, 3H, OCH3), 6.86
(s, 1H, vinyl-CH), 7.82 (t, 1H, Ar-H, J = 8.1 Hz), 8.01 (d, 1H, Ar-H, J = 7.2 Hz), 8.30 (t, 1H, Ar-H, J =
7.9 Hz), 8.45 (d, 1H, Ar-H, J = 7.8 Hz), 8.65 (d, 1H, Ar-H, J = 8.2 Hz), 8.36 (d, 1H, Ar-H, J = 8.0 Hz).
13C-NMR (100 MHz, DMSO-d6): δ = 12.29 (CH3), 31.5 (CH2), 52.52 (OCH3), 116.37 (vinyl-CH), 126.02,
127.46, 128.85, 129.66, 130.03, 131.30 (Ar-CH), 132.37, 135.30, 139.91, 140.74 (Ar-C), 144.24 (thiazole-C5),
154.92, 160.66 (thiazole-C2, C=N), 164.13 (cyclic-C=O), 165.66 (ester C=O), 187.49 (C=O). MS, m/z (%) =
393 (M+, 20), 306 (40), 153 (100), 136 (60), 107 (17). Anal. Calcd. for C20H15N3O4S (393.42); C, 61.06; H,
3.84; N, 10.68; S, 8.15. Found: C, 61.16; H, 3.81; N, 10.75; S, 8.20.
Tetramethyl 5-(2-(((Z)-N-allyl-N′-((E)-2-oxoacenaphthylen-1-(2H)-ylidene)carbamo-hydrazonoyl)thio)-1,2,3-
tris(methoxycarbonyl)cyclopropyl)-4-methoxy-7-oxabicyclo-[2.2.1]hepta-2,5-diene-1,2,3,6-tetracarboxylate (8d).
Yield: (0.086 g, 10%); orange crystals (EtOH); m.p.: 224–226 ◦C. IR (KBr): ν = 3401 (NH), 3100 (Ar-CH),
2953 (Ali-CH), 1717, 1698 (CO), 1623 (C=N), 1590 (Ar-C=C) cm−1. 1H-NMR (400 MHz, DMSO-d6): δ =
3.13 (s, 1H, cyclopropane-H), 3.40 (s, 3H, OCH3), 3.46, 3.55, 3.65, 3.73, 3.80, 3.85, 3.95 (s, 3H, OCH3), 4.40
(m, 2H, allyl-CH2N), 5.36 (m, 2H, allyl-CH2=), 6.08 (m, 1H, allyl-CH=), 7.77 (t, 1H, Ar-H, J = 8.2 Hz),
7.81 (t, 1H, Ar-H, J = 7.91 Hz), 8.00 (d, 1H, Ar-H, J = 7.1 Hz), 8.05 (d, 1H, Ar-H, J = 7.7 Hz), 8.11 (d, 1H,
Ar-H, J = 8.3 Hz), 8.24 (d, 1H, Ar-H, J = 8.1 Hz), 9.40 (s, IH, NH-allyl). 13C-NMR (100 MHz, DMSO-d6):
δ = 22.23, 24.90 (cyclopropane-C), 25.60 (cyclopropane-CH), 46.81 (allyl-CH2N), 52.00, 52.20, 52.60,
53.07, 53.19, 53.53, 53.65, 54.17 (OCH3), 118.19 (allyl-CH2=), 134.22 (allyl-CH=), 119.91, 121.80, 128.52,
128.29, 130.00, 132.32 (Ar-CH), 94.66, 121.66, 131.44, 134.58, 136.84, 138.01, 138.22, 138.93, 140.41, 142.82
(Ar-C), 152.63, 154.82 (C=N), 165.21, 167.53, 168.91, 171.68, 172.00, 173.51, 175.44 (ester-C=O), 185.16
(C=O). MS, m/z (%) = 863 (M+, 10), 805 (5), 612 (20), 307 (35), 154 (100), 137 (67), 107 (18). Anal. Calcd.
for C40H37N3O17S (863.80); C, 55.62; H, 4.32; N, 4.86; S, 3.71. Found: C, 55.69; H, 4.27; N, 4.79; S, 3.61.
Preparation of 4-Acetyl-[2.2]Paracyclophanylidene-Thiosemicarbazones 22a,f
4-Acetyl[2.2]paracyclophanylidene-thiosemicarbazones 22a,f were synthesized via refluxing
solutions of 4-acetyl[2.2]paracyclophane (21) (2.50 g, 10 mmol) in absolute ethanol (100 mL)
containing glacial acetic acid (0.5 mL) and thiosemicarbazide 2a (0.91 g, 10 mmol) or (1.06 g,
10 mmol) of thiocarbohydrazide 2f for 6 h. Compounds 22a,f were precipitated, then filtered
and washed with dry ethanol to get the crude as colorless crystals. On the other hand,
Bis-4-acetyl[2.2]-paracyclophanylidene-hydrazine-1-carbothiohydrazide (23) was obtained efficiently
after treating 21 (2.50 g, 10 mmol) with 2f (0.53 g, 5 mmol) in absolute EtOH (50 mL) under the same
condition mentioned before (Scheme 7).
(E)-2-(4-([2.2]Paracyclophanylethylidene)-1-carbothiohydrazide (22f). Yield: (2.03 g, 60%); colorless crystals
(EtOH/DMF); m.p.: 188–189 ◦C. IR (KBr): ν = 3450–3344 (NH), 2926–2853 (Ali-CH), 1642 (C=N), 1617
(Ar-C=C), 1354 (C=S) cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 2.28 (s, 3H, CH3), 2.79 (m, 2H,
PC-CH2), 2.98 (m, 4H, 2 PC-CH2), 3.40 (m, 2H, PC-CH2), 4.99 (b, 2H, NH2), 6.49 (m, 6H, PC-H), 6.86 (s,
Molecules 2019, 24, 3069 14 of 20
1H, PC-H), 9.37 (s, 1H, NH), 10.10 (s, 1H, = N-NH). 13C-NMR (100 MHz, DMSO-d6): δ = 18.04 (CH3),
34.38, 34.71, 34.84 (Pc-CH2), 130.56, 131.62, 132.23, 132.92, 132.50, 132.41, 135.61 (Pc-CH), 137.89, 138.97,
139.15, 139.45 (Pc-C), 150.68 (C = N), 177.17 (C = S). MS: m/z (%) = 338 [M+, 50], 306 (30), 153 (100), 135
(75), 106 (26). Anal. Calcd. for C19H22N4S (338.47); C, 67.42; H, 6.55; N, 16.55; S, 9.47. Found: C, 67.46;
H, 6.50; N, 16.49; S, 9.53.
Bis-4-acetyl[2.2]paracyclophanylidene-hydrazine-1-carbothiohydrazide (23). Yield: (4.14 g, 88%); colorless
crystals (EtOH/ DMF); m.p.: 224–226 ◦C. IR (KBr): ν = 3450–3344 (NH), 2926–2853 (Ali-CH), 1642
(C=N), 1617 (Ar-C=C), 1354 (C=S) cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 2.29 (s, 6H, 2CH3), 2.35
(m, 4H, PC-CH2), 2.97 (m, 8H, PC-CH2), 3.10 (m, 4H, PC-CH2), 6.48–6.56 (m, 4H, PC-H), 6.82 (s, 2H,
PC-H), 7.08–7.09 (m, 8H, PC-H), 10.25 (s, 2H, 2=N-NH). 13C-NMR (100 MHz, DMSO-d6): δ = 18.56,
18.69 (CH3), 34.38, 34.59, 34.71, 34.83 (PC-CH2), 130.57, 131.60, 131.90, 132.23, 132.61, 133.20, 133.40
(PC-CH), 135.61, 135.75, 138.23, 139.15, 139.24 (PC-C), 150.93 (C=N), 177.32 (C = S). MS: m/z (%) = 570
[M+, 20], 363 (15), 351 (25), 307 (34), 154 (100), 106 (20), 98 (63). Anal. Calcd. for C37H38N4S (570.79); C,
77.86; H, 6.71; N, 9.82; S, 5.62. Found: C, 77.97; H, 6.63; N, 9.94; S, 5.75.
2,2′-(1,4(1,4)-Dibenzenacyclohexaphane-12,43-diylbis(methane-ylylidene))bis-(N-cyclohexyl-hydrazine-1-
carbothioamide) (25). Yield: (4.59 g, 80%); colorless crystals (CH3CN); m.p.:142–143 ◦C. IR (KBr): ν = 3440
(NH), 2953 (Ali-CH), 1637 (C=N), 1610 (Ar-C=C), 1350 (C=S) cm−1. 1H-NMR (400 MHz, DMSO-d6): δ
= 1.39 (m, 4H, cyclohexyl-CH2), 1.75 (m, 8H, cyclohexyl-CH2), 1.92 (m, 8H, cyclohexyl-CH2), 2.55 (m,
2H, cyclohexyl-CH), 2.90 (m, 4H, 2 PC-CH2), 3.23 (m, 2H, PC-CH2), 3.55 (m, 2H, PC-CH2), 6.52 (m, 4H,
PC-H), 6.75 (s, 2H, PC-H), 7.55 (d, 2H, NH-cyclohexyl), 8.15 (s, 2H, CH=N), 11.20 (s, 2H, =N-NH).
13C-NMR (100 MHz, DMSO-d6): δ = 25.92, 32.50, 34.60 (cyclic-CH2), 32.58, 34.65, 34.88, (PC-CH2),
130.07, 132.40, 133.24 (PC-CH), 135.52, 138.14, 138.80, 139.90 (PC-C), 142.50 (CH=N), 175.06 (C = S). MS:
m/z (%) = 574 [M+, 3], 417 (4), 261 (13), 258 (18), 157 (4), 141 (29), 129 (98), 83 (33), 56 (100). Anal. Calcd.
for C32H42N6S2 (574.29); C, 66.86; H, 7.36; N, 14.62; S, 11.16. Found: C, 66.90; H, 7.42; N, 14.64; S, 11.10.
Reactions of 4-Acetyl[2.2]Paracyclophanylidene-Thiosemicarbazones, 22a,f with 6a and 6b
A mixture of 22a,f (1 mmol) in absolute ethanol (50 mL) was refluxed with either 6a or 6b for 3
h and the reaction was monitored by TLC. The precipitate of 26–29 was formed after concentration
the solvent under vacuum, was filtered and washed with cold ethanol (15 mL) and recrystallized
from methanol.
Methyl 2-((Z)-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)hydrazine-ylidene)-4-
oxothiazolidin-5-yl)acetate (26). Yield: (0.355 g, 82%); yellow crystals; m.p.: 256–258 ◦C. IR
(KBr) ν = 3260 (NH), 3110 (Ar-CH), 2925 (Ali-CH), 1713, 1699 (CO), 1626 (C=N), 1600 (Ar-C=C) cm−1.
1H-NMR (400 MHz, DMSO-d6): δ = 2.37 (s, 3H, CH3), 2.89 (m, 8H, PC-CH2), 3.77 (s, 3H, OCH3), 6.54
(s, 1H, PC-H), 6.68 (m, 6H, PC-H), 6.74 (s, 1H, vinyl-CH), 12.89 (s, 1H, NH-thiazole). 13C-NMR (100
MHz, DMSO-d6): δ = 18.33 (CH3), 34.54, 34.60, 34.76, 35.02 (PC-CH2), 52.38 (OCH3), 113.92 (vinyl-CH),
130.81, 132.08, 132.37, 132.58, 132.70, 133.63, 135.82 (PC-CH), 138.23, 138.54, 138.97, 139.22 (PC-C),
143.54 (thiazole-C5), 159.05, 165.09 (thiazole-C2, C=N) 165.92 (cyclic-C=O), 165.99 (ester C=O). MS,
m/z (%) = 433 (M+, 43), 306 (40), 289 (17), 153 (100) 136 (65), 106 (15). Anal. Calcd. for C24H23N3O3S
(433.52); C, 66.49; H, 5.35; N, 9.69; S, 7.40. Found: C, 66.52; H, 5.46; N, 9.57; S, 7.33.
Methyl 2-((Z)-3-amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazineylidene)-4-
oxothiazolidin-5-yl)acetate (27). Yield: (0.349 g, 78%); yellow crystals (CH3OH); m.p.: 260–262 ◦C. IR
(KBr) ν = 3337 (NH2), 3050 (Ar-CH), 2923 (Ali-CH), 1737, 1700 (CO), 1630 (C=N), 1603 (Ar-C=C) cm−1.
1H-NMR (400 MHz, DMSO-d6): δ = 2.35 (s, 3H, CH3), 2.90 (m, 8H, PC-CH2), 3.80 (s, 3H, OCH3),
6.65 (m, 6H, PC-H), 6.55 (s, 1H, PC-H), 6.75 (s, 1H, vinyl-CH), 6.90 (br, s, 2H, NH2). 13C-NMR (100
MHz, DMSO-d6): δ = 18.61 (CH3), 34.51, 34.57, 34.75, 34.89 (PC-CH2), 52.61 (OCH3), 114.19 (vinyl-CH),
130.48, 131.52, 132.24, 132.38, 132.58, 133.34, 135.68 (PC-CH), 138.11, 138.86, 139.97, 139.17 (PC-C),
144.51 (thiazole-C5), 152.36, 161.06 (thiazole-C2) 165.90 (cyclic-C=O), 166.77 (ester C = O). MS, m/z (%)
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= 448 (M+, 7), 306 (30), 289 (15), 153 (100) 136 (64), 106 (20). Anal. Calcd. for C24H24N4O3S (448.54); C,
64.27; H, 5.39; N, 12.49; S, 7.15. Found: C, 64.39; H, 5.48; N, 12.37; S, 7.31.
Ethyl 2-((Z)-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)hydrazine-ylidene)-4-oxothiazolidin-
5-yl)acetate (28). Yield: (0.380, 85%); yellow plates (CH3OH); m.p. 200–202 ◦C. IR (KBr) ν = 3240 (NH),
3120 (Ar-CH), 2919 (Ali-CH), 1714, 1695 (CO), 1624 (C=N), 1592 (Ar-C=C) cm−1. 1H-NMR (DMSO-d6):
δ = 1.27 (t, 3H, CH3, J = 7.1 Hz), 2.37 (s, 3H, CH3), 2.90–3.14 (m, 8H, PC-CH2), 4.24 (q, 2H, OCH2, J =
7.1 Hz), 6.56–6.61 (m, 6H, PC-H), 6.54 (s, 1H, PC-H), 6.70 (s, 1H, vinyl-CH), 12.90 (s, 1H, NH-thiazole).
13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-CH2), 61.25
(OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 138.17, 138.55,
138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 (cyclic-C=O),
165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. Calcd. For
C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 7.28.
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine-ylidene)-4-
oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 ◦C.
IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C)
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04
(m, 8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H,
vinyl-CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57,
34.66, 34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40,
132.60, 132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17,
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25),
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C,
64.91; H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02.
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses were
carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector at
123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O)
free). Semi-empirical absorption corrections were applied.
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 ×
0.20 mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2)
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Foun : C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Deter ination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, b = 18.2558 (7)
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1H, H-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 1 01 18 36 (CH3) 4 5 , 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138. 7, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic- = ), 165.62 (ester C=O). S, m/z (%) = 447 (M+, 62 306 32 53 1 0), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5 63; N, 9.39; S, 7.16. Foun : C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 ( =N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 z), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2) 4.2  (q, 2H, OCH2, J = 7.2 Hz), 6. 8 (m, 6 , P - ), 6.57 (s, 1 , PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18. 2 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH ), 54.40 (OCH3), 2.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143. 6 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). S, m/z (%) = 462 (M+, 6), 307 (25), 
2 8 (40), 155 (27 54 9 43 1 0), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determinatio  of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C H5OH (ethanol), 25 from CH3CN ( cetonitrile), nd a single crystal of 28 was obtained 
acenaph hequin e recrystallization from CH3OH (methanol). The single-cry tal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Phot n II CPAD detector 
at 123K usi g Cu-Kα radiation (λ = 1.54178 Å). Direct Meth ds (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) we used for structure solution and refinement was carried out using SHELXL-2014 
(f ll-matrix least-squares on F2) [59]. Hyd ogen atoms we e refined using a riding model (H (N, O) 
free). Semi-empi ical absorption corr ctions were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)° V 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all dat ) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, m noclinic, space group P21/n no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c  16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3 27 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 1 .460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disorde ed, but the disorder is n t resolved. Use of 
co straints (EADP) and restraints (SADI) for the refinement as well as a ge eral RIGU restraint. 
, c = 20.0737 (7)
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single c ystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a le crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 wa  obtain d 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, β = 97.327 (1)◦, V = 2302.83 (14)
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14 1, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 39.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-y )acetate (29). Yield: (0.374 g, 8 %); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH ), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.7 , 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, .93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5  was btained by rec ystalliza ion from C2H5OH (ethanol), a single crystal 
f 7d was obtained by recrystallization from C2H5OH (etha ol), a single rystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), d a single crystal of 28 was obtained 
acenaphthequinone recrystallizatio  from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffract meter with Ph ton100 or Photon II CPAD detector 
at 23K using Cu-Kα ra iation (λ = 1. 4178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solutio  and refinement was carried out using SHELXL-2014 
(full-matrix least-squares o  F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi- m irical absorption corrections were applie .  Ǻ 
Compound a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg −3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured r fl ctio s (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 ( )°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg −3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] 0 29, wR2 (for all d ta) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1 23 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measure  reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1 13 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
isordered, disordered atoms refined isotropic lly. In e second molecule the oxacenaphthylene 
moiety sh ws high Uij-value , probably disorder , but the disorder is not resolved. Use of 
constraints (EADP) a d restraint  (SADI) for the refinement as well as a general RIGU restraint. 
3, Z = 8, Dcalcd = 1.47 Mg m−3, F (000) = 1056, µ (Cu-Kα) =
2.42 mm−1, T = 123 K, 19236 measured reflections ( θmax = 144.2 ◦), 4 10 independent reflections
[Rint = 0.023], 343 parameters, 6 restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) =
0.079, S = 1.06, largest diff. peak and hole = 0.37 e
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calc . For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin 5-yl)acetate (29). Yield: (0.374 g, 81%); y llow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = .2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Fo nd: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Metho s (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-e pirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide ethanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 easured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
−3/−0.31 e
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), .53, 4.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
38.17, 138.55, 138.96, 139.2  (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O . MS, m/z (%) = 447 M+, 62), 306 (32), 153 (10 ), 135 (65), 106 (20). Anal. 
alcd. For C25 25N3O3S (447.55): C, 67.09; , 5.63; N, 9.39; S, 7.1 . Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-( (E) 1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl ethyl d ne)-hydrazine- 
ylidene)-4-oxothi zolidin-5-yl)a etate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 31 0 (Ar-CH , 2924 (Ali-CH), 1735, 1720 (CO), 22 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = .28 (t, 3H, CH3, J = 7.2 Hz), 2.3  (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-C 2), 4.27 (q, 2H, OCH2, J = 7.2 Hz) 6.68 (m, 6H, PC- ), 6.57 (s, 1H, PC- ), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 4 38 18 62 (CH3) 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 13 .81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.0  (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%  = 462 (M+, 6), 307 (25), 
248 (40), 15  (27), 154 (95), 143 (10 ), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7. 2. 
3.2. Single Crystal X-ray Structure Determination of 5 , 7d, 8d, 25 and 28 
A single cry tal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization fro  CH3OH (m tha ol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Ventur  diffractome er with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution a d refinem nt was carried out using SHELXL-2014 
(full matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-em irical absorptio  co r ctions were applied.  Ǻ 
Compound 5a (SB 184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, spa e group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.4  mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O S, Mr = 405.42 g mol−1, yellow blocks, size 12 × 0.06 × 0.04 
mm, monoclinic, space gr up P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.69 4 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest iff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O1 S, Mr = 863.78  mol−1, orange plates, size 9 × 0.06 × 0.03 
mm, triclinic, space group P-  (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 ( ) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104. 6  (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,02  I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest iff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the v nyl moiety is 
, disordered atoms ref ned isotropically. In the second mole ule t e oxac naphthylene 
moiety shows high Uij-values, probably disord re , but the disorder is not r s lved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as wel as a general RIGU restraint. 
−3. It is a polymorph of EBINOV
(2-(2-oxoacenaphthyle -1(2H)-ylid ne)hydrazinecarbothioamide methanol solvate) [60].
C mpound 7d (SB1186_HY): C21H15N3O4S, Mr = 40 .42 g mol−1, yellow blocks, size 0.1 × 0.06 ×
0.04 mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2)
Molecules 2019, 24, x FOR P ER REVIEW 15 of 19 
1H, NH-thiazole). 13C-NM  (100 MHz, DMSO-d6): δ = 14.01, 18. 6 (CH3), 34.53, 34.61, 34.75, 35.03 (P -
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 1 2.70, 1 3.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 14 .90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 ( 5), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67. 2; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)ac tate 9 . Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 ( 3), 18.62 (CH3 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC- H), 138.27, 1 8.60, 138.99, 139.25 (PC-C), 143.56 ( hiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z %) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. f r C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02.
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a wa  obtain d by recryst llization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by crystallization from C2H5OH (ethanol), a single crystal f 8d was o tained 
fro  C2H5OH (ethanol), 25 fr m CH3CN ( cetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-r y analyses 
were c rri  out on a Bruker D8 Venture diffractomet r with Photo 100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.5 17  Å). Direct Methods (SHELXS [58] or Dual Space Metho s 
(SHELXT [59]) were used for structure solution and refinement was carried ut using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrog n atoms were refined using a riding model (H (N, O) 
free). Se i-empirical absorption corrections were applied.  Ǻ 
Co pound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 10 6, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured r flections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 05.4  g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16. 943 (5) Ǻ, β = 
98.917 (1)°, V = 8 2.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independ nt refl ctions [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, b = 15.6914 (5)
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1H, H-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 8.3  (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-C ), 1 0.79, 132.09, 132. 6, 1 2.58, 1 .70, 1 3.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (P -C), 142.90 (thiazole-C5), 158.45, 1 5.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 0  (32), 5  (10 , 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C 67. 2; H, 5.66; N, 9.45; S, 
7.28. 
E yl 2-((Z)-3-Amino 2-(((E)-1-(1,4(1,4)-dibe z nacyclohexaphane-12-yl)ethylidene)-hydrazine- 
y e e) 4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 29 4 (Ali-CH), 735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-N R (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), .33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-N R (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (P -CH2), 54.40 (OC 3), 62.0 (OCH2), 11 .46 (vinyl-CH), 131.8 , 132.18, 132.40, 132.60, 
132.73, 135.72 4 86 (P -CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 ( hiaz le-C5), 159.17, 
166.02 (thiazol -C2, C=N), 165.95 (cycl c-C=O), 176.02 ( ster C O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 40 55 27), 154 (95), 143 (10 , 135 (65), 106 (20). Anal. Calcd. for C25H26N O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C 65 01 H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X- ay Structure Determination of 5 , 7d, 8d, 25 and 28 
A single crystal of 5a was obta ned by ecrystallization from C2H5OH (ethanol), a single crystal 
of 7d was bta ned by ecrystallization fro  C2H5OH (ethanol), a single crystal of 8d was obtained 
from C H5OH (etha l), 25 fr m CH3CN (aceto itrile), and a single crys l of 28 was obtained 
acen phthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out o  a Bruker D8 V ntur  diffrac m ter wit  Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ  1.54178 Å). Direct Methods (SHELXS [58] r Dual Space Methods 
(SHELXT [59]) were used for structure s lution nd ref nement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydroge  atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB 184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, m noclinic, space group P21/c no.1 ), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302. 3 ( 4) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000 1056, μ (Cu-Kα) 2.42 mm−1, Τ = 123 K, 19 36 
measured reflections (2θmax = 144.2 °), 451  independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph f EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamid  methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 05. 2 g mol−1, yellow blocks, size 0.12 × 0.06 × .04 
mm, monoclinic, space group P21/n ( o.14),  = 7.0903 (2) , b  5.6 1  ( ) , c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1 2.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured r flections (2θmax = 144.4°), 3575 independent reflecti ns [Rint = 0.024], 263 
param ters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for ll data) = 0.077, S = 1.06, l rg st diff. pe k and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a  2.886  (5) , b  15.1023 (6) , c 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 1 4. 60 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 pa meters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, l rgest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
isordered, disordered at ms refined isotropically. In the second molecule the oxacenaphthylene 
moiety show  high Uij-values, proba ly disordere , but the dis rder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for th  refinement s well as a general RIGU restraint. 
, c = 16.4943 (5)
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1H NH-thiazole). 13 -N R (100 MHz, DMSO-d6): δ = 14. 1, 18.3  ( H3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 1 0.79, 132.09, 13 . 6, 132.58, 13 .70, 13 .70, 135.82 (PC-CH), 
138.17, 138.55, 138.9 , 139.22 (PC-C), 142.90 (thiazole-C5 58 45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 6 ), 306 (32), 153 (10 , 135 (65), 106 (20). Anal. 
alcd. For C25H25N3O3S (447.55): 67.09; H, 5.6 ; N, 9.39; S, 7. 6. Found: C 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z -3-Amino-2-(((E) -(1,4( ,4)-dib zenacyclo exaphane-12-yl)ethylidene)-hydrazine- 
y e e) 4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
° . IR (KBr): ν = 3344 (NH), 310 (Ar-CH), 924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-N R (400 MHz, DMSO-d6): δ = 1.28 (t, 3H CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H PC-CH2), 4.27 (q 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-N R (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (P -CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vin l-CH), 131.8 , 132.18, 132.40, 132.60, 
13 .73, 135.7 4 86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C O . MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 55 (27), 154 (95), 143 (10 , 135 ( 5), 106 (20). Anal. Calcd. for C25H26N O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C 65 01 H, 5.75; N, 12.16; S, 7.02. 
3.2. S gle Cryst l X- ay Structure Det r ination of 5a, 7 , 8d,  an  28 
A single crystal of 5a was obta ned by ecryst llization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by ecryst lliz tion fr m C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H OH (e hanol), 25 fr m CH3CN (aceto itril ), and a single crys l of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out o  a Bruke  D8 Ventu e diffrac meter wit  Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Dir ct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were u ed for stru tu e solutio  and ref nement was carried out using SHELXL-2014 
(full-matrix le st-squares n F2) [59]. Hyd oge  at ms were refined using a riding model (H (N, O) 
free). Semi- mpirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1 84_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, m noclinic, space group P21/c no.14), a = 6.3357 (2) Ǻ, b = 18. 558 (7) Ǻ, c  20.0737 (7) Ǻ, β = 97.327 
( )°, V = 2302.83 1 ) Ǻ3, Z = 8, Dcalcd = 1.473 Mg −3, F (000  1 56, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 45 0 independent reflectio s [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = .030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is  polymorph f EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 4 5.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
, monoclinic, space group P21/n (no.14) a  7.0903 (2) Ǻ, b = 15.6914 (5) , c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = , Dcalcd = 1.485 Mg m−3, F ( 00   840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 180 1 measured reflections (2θ ax = 144.4°), 3575 ind pendent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all dat ) = 0.077, S = 1.06, l rgest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2) a = 2 886 5 b 5.1 3 (6) , c  22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 1 4 60 (2)°, V = 4000.4 3) Ǻ3, Z = 4 Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 pa meters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
 .10, l rgest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
isordered, disord red at ms refined isotropically. In t e second molecule the oxacenaphthylene 
moiety show  high Uij-values, p oba ly diso dere , but the di rder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement s well as a general RIGU restraint. 
, β
= 98.917 (1)◦, V = 18 2.92 (9)
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1H, NH-thiazole). 13C-NMR ( 00 MHz, DMSO-d6): δ = 14.0 , 18.36 (CH3), 34.53, 34.6 , 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-C ), 130.79, 132.09, 132.36, 132.58, 13 .70, 133.70, 1 5.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; , 5. 3; N, 9.39; S, 7.16. Fou d: , 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29)  Yie d: (0.374 g, 81%); yellow crystals (CH3O ); m.p. 174– 75 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, H3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2 J = 7.  Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, viny -
CH), 10.09 ( , s, 2H, NH2). 13C-NMR ( 00 M z, DMSO-d6): δ = 4.38 (CH3), 8.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC- H2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole- 2, C=N), 165.95 (cyc ic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, .11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3. . Single Crystal X-ray Structure Deter inatio  of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a singl  crystal
of 7d was obtained by recrystallizatio  from C2H5OH ( thanol), a s ngle crystal f 8d w s obtained 
from C2H5OH (ethanol), 25 from CH3CN ( c tonitrile), and a sin le crystal of 28 was obtain d 
acenaphthequinone recrystallizat on from CH3OH ( ethan l). The single-crystal X-ray analyses 
were carri d out on a Bruker D8 Venture diffractometer with Photo 100 r Photon II CPAD det ctor 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Metho s (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and r finement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydr gen atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compou d 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g m l−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, mono linic, space group P 1/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β  97.327 
(1)°, V = 302.83 ( ) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independ nt reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, r = 4 5. 2 g mol−1, yellow blocks, size 0.12 × 0. 6 × 0.04 
mm, onoclinic, space group P21/n (no. 4), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F ( 0 ) = 40, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 1804  measured reflections (2θmax = 144.4°), 3575 i d pende t r flections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (f r all data) = 0.077, S = 1.06, largest diff. pe k and 
hole = 0.28 e Ǻ−3/−0.30  Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 ind pend nt refl c ions 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, µ (Cu-Kα) 1. 0 mm−1 T
= 123 K, 18041 measured reflection (2θmax = 144.4◦), 3575 inde endent reflections [Rint 0.024], 263
parameters, R1 [for 3402 I › 2σ (I)] 0.029, wR2 (for all data) 0.077, S = 1.06, largest diff. peak and
hole = 0.28 e
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (C 3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 1 5.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 6 ), 3 6 (32), 153 (100), 135 (65), 106 (2 ). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol),  single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acet nitrile), d a single crystal of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-cryst l X-ray analyses 
were carried out on a Bruker D8 Venture diffracto et r with Photon100 or Photon II CPAD etector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] r Dual Sp ce Methods 
(SHELXT [59]) were used for structure solution and refinement was carried ut using SH LXL-2014 
(full-matrix least-squares on F2) [59]. Hydroge  ato s were refined usi g a riding del (H (N, O) 
free). Semi-empirical absorption corrections were a plie .  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g l−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 7) Ǻ, β = 97.327
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 m−1, Τ = 123 K, 192 6 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint 0.023], 343 parameters, 6
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0. 79, S = 1.06, largest diff. peak and hole = 0.3  
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g ol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 inde e ent r flections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
3/− .30 e
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1H, NH-thiazole). 13C-N R (100 MHz, DMSO-d6): δ = 4.01 18 36 (CH3) 3 4 6 , 3 .75, 35. 3 (P -
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132. 6, 132.58, 132.70  133.70, 135.8  (PC-CH), 
138.17, 138.55, 138.96, 139.2  (P - ), 142.90 (thiazole- 5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 6 ), 306 (32), 153 (100), 35 (65), 106 (20). Anal. 
Calcd. For C25H2 N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 7.12; , 5.66; N, 9. 5; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dib nzen cyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothi zolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 17 0 (CO 22 C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.3  (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC- ), 6.57 (s, 1H, PC- ), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 4.38 ( 3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazol -C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6 , 307 (25), 
248 (40), 15  (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S ( 62.56): C, 64.91;
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5 , 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 fro  CH3CN (acet nitrile), nd a single crystal of 28 was obtained 
acenaphthequinone recrystallization fro  CH3OH (m tha o ). The single-cryst l X-ray analyses 
were carried out on a Bruker D8 V ntur  diffractome er with Ph t n 00 or Photon II CPAD tector
at 123  using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] r Dual S ace Methods 
(SHELXT [59]) were used for structure solution d refine ent was carried out using SHELXL-20 4 
(full- atrix least-squares on F2) [59]. Hydrogen atoms were refined usi g a riding model (H (N, O) 
free). Semi-em irical absorption co rections w re applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mo −1, orang blocks, size 0.30 × 0.2  × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 ( ) Ǻ, c = 20.073  (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.4  m−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 ind pendent reflections [Rint = 0.023], 3 3 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0. 30, wR2 (for all data) = 0. 79, S = 1.06, largest iff. peak and hol  = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymor h of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylid ne) 
hydrazinecarbothio mide me hanol solvate) [60]. 
Compound 7d (SB1 86_HY): C21H15N3O S, Mr = 405. 2 g mol−1, yellow blocks, size .12 × 0.06 × 0.04 
m monoclinic, space gr up P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 m asured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
para eters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak an  
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O1 S, Mr = 863.78 g mo −1, orange plates, size . 9 × 0.06 × 0.03 
mm, triclinic, space group P-  (no. 2), a = 12.8863 (5) Ǻ, b = 15.10 3 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104. 6  (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 rest aints, R1 [for 14,02  I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. p ak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the v nyl moiety is 
, disordered atoms ref ned isotropically. In the second m lecule t e oxac naphthylene 
moiety shows high Uij-values, probably disordere , but the disorder is not r s lved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as wel as a general RIGU restraint. 
−3.
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Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 ×
0.03 mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5)
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Se i-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, b = 15.1023 (6)
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1H, H-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 1 01 18 36 (CH3) 4 5 , 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). S, m/z (%) = 447 (M+, 62 , 306 32 , 53 1 0), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5 63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 ( =N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 z), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.2  (q, 2H OCH2, J = 7.2 Hz), 6. 8 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10 09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH ), 54.40 (OCH3), 2.0 (OCH2), 1 5.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). S m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determinatio  of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C H5OH (ethanol), 25 from CH3CN ( cetonitrile), and a single crystal of 28 was obtained 
acenaphthequin e ecrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Pho n II CPAD detector 
at 123K usi g Cu-Kα radiation (λ = 1.54178 Å). Direct Meth ds (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) we used f r structure solution and efinement was carried out using SHELXL-2014 
(f ll-matrix least-squares on F2) [59]. Hydrogen atoms we e refined using a riding model (H (N, O) 
free). Semi-empi ical absorption corr ctions were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclini , space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0 37 (7) Ǻ, β = 97.327 
(1)°, V  2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all dat ) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, m noclinic, space group P21/n no.14), a = 7.0903 (2) , b = 15.6914 (5) , c 16.4943 (5) Ǻ, β = 
98. 17 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 84 , μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 1 4.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disorde ed, but the disorder is n t resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a ge eral RIGU restraint. 
, c = 22.3027 (8)
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1H, H-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 1 . 1, 18.36 (CH3), 4.5 , 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 1 4.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96 39 22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). S, m/z (%) = 447 (M+, 62), 306 (32), 53 (1 0), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
yliden )-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 31 0 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 ( =N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, H, CH , J = 7.2 z), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H OCH2, J = 7.2 Hz), 6. 8 (m, 6H, PC-H), 6.5  (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10 09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH ), 2.0 (OCH2), 1 5.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.7 , 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C O), 176.02 (ester C=O). S m/z (%) = 462 (M+, 6), 307 (25), 
248 40 , 55 7 , 154 (95), 143 (100), 135 (65), 106 ( 0). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray S ructure Determinatio  of 5a, 7d, 8d, 25 and 28 
A single cryst l f 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
f 7d was obtained by recrystallization from C2H5OH (etha ol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN ( cetonitrile), nd a single crystal of 28 was obtained 
acenaphthequin e ecrystallizatio  from CH3OH (methanol). The single-crystal X-ray analyses 
were car ied out on a Bruker D8 Venture diffractometer with Photon100 or Pho n II CPAD detector 
at 123K usi g Cu-Kα ra iation (λ = 1. 4178 Å). Direct Meth ds (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) w  used f r structure solutio  nd efinement was carried out using SHELXL-2014 
(f ll-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-em irical absorption corr ctions were applied.  Ǻ 
Compound a (SB1184_HY): C13H N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclini , space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0 37 (7) Ǻ, β = 97.327 
(1)°, V 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg −3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured r fl ctio s (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 ( or all dat ) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n no.14), a = 7.0 03 (2) Ǻ, b = 15.6914 (5) , c 16.4943 (5) Ǻ, β = 
98 17 ( )°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg −3, F (000) = 84 , μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 180 1 measured reflectio s (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] 0 29, wR2 (for all d ta) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H3 N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 1 4.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measure  reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In  2nd molecule the vinyl moiety is 
isordered, disordered atoms refin d isotropic lly. In  second molecule the oxacenaphthylene 
moiety sh ws high Uij-values, probably disorde , but the disorder is not resolved. Use of 
constrain s (EADP) a d res raint (SADI) for the refinement as well as a ge eral RIGU restraint. 
, α
= 100.800 (2)◦, β = 00.850 (2)◦, γ = 04.460 (2)◦, V = 4000.4 (3)
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioami e methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
3, Z = 4, Dcalcd 1.434 Mg m−3 F
(000) = 1800, µ (Cu-Kα) = 1.43 mm−1, T = 123 K, 1781 measured reflections (2θmax = 144.4◦), 15705
independent reflections [Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14 020 I › 2σ (I)] = 0.059,
wR2 (for all data) = 0.148, S = 1.10, argest diff. peak and hole = 1.52 e
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 6 ), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Fou d: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix leas -squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-e pirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide ethanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 g m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
−3/−0.59 e
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), .53, 4.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.2  (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 M+, 62), 306 (32), 153 (10 ), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.1 . Found: , 7.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethyl d ne)-hydrazine- 
ylidene)-4-oxothi zolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 17 0 (CO , 22 C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.3  (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-C 2), 4.27 (q, 2H, OCH2, J = 7.2 Hz) 6.68 (m, 6H, PC- ), 6.57 (s, 1H, PC- ), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 4 38 18 62 (CH3) 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 13 .81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.0  (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 15  (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5 , 7d, 8d, 25 and 28 
A single cry tal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 28 was obtained 
acenaphthequinone recrystallization fro  CH3OH (m tha ol). The single-crystal X-ray analyses 
were carried out on a Bruker D8 Ventur  diffractome er with Photon100 or Photon II CPAD detector 
at 123  using Cu-Kα radiation (λ = 1.54178 Å). Direct ethods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution a d refinement was carried out using SHELXL-2014 
(full matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-em irical absorptio  co rections were applied.  Ǻ 
Compound 5a (SB 184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orang  blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, spa e group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.4  mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e −3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide me hanol solvate) [60]. 
Compound 7d (SB1 86_HY): C21H15N3O S, Mr = 405.42 g mol−1, yellow blocks, size 12 × 0.06 × 0.04 
mm monoclinic, space gr up P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.69 4 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 asured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest iff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O1 S, Mr = 863.78  mol−1, orange plates, size 9 × 0.06 × 0.03 
mm, triclinic, space group P-  (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104. 6  (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,02  I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest iff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the v nyl moiety is 
, disordered atoms ref ned isotropically. In the second m le ule t e oxac naphthylene 
moiety shows high Uij-values, probably disordere , but the disorder is not r s lved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as wel as a general RIGU restraint. 
−3. In the 2nd
molecule th viny moiety is disordered, disordered atoms r fined iso r pically. In the second molecul
the oxacenaphthylene moiety shows high Uij-values, probably disordered, but the disorder is not
resolved. Use of cons raints (EADP) and restraints (SADI) for the refinement as well as a general
RIGU restraint.
Comp und 25 (SB1014_HY): C32H42N6S2 · .5 C2H5N, Mr = 595.36 g mol−1, colorles blocks, size 0.40
× 0.18 × 0.06 mm, triclinic, space group P-1 (no.2), a = 13.7588 (6)
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1H, NH-thiazole). 13C-NMR (100 M z, DMSO-d6): δ = 14.0 , 1 .36 (CH3), 34.53, 4.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 30.79, 132.09, 132.36, 132. 8, 132.70, 133.70, 135.8  (PC- ), 
138.1 , 138.55, 138.96, 139.22 (PC-C), 42.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 1 5.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 30  (32), 153 (100), 35 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (44 .55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.1 ; H, 5.6 ; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Al -CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO- 6): δ = 1.28 (t, 3H, CH3, J = 7.2 z), 2.33 (s  3 , C 3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 z), 6.68 (m, 6H, PC-H), 6.57 ( , 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 M z, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vi yl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 1 4.86 (PC-CH), 3 .27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cycl c-C=O), 176.02 (es e C=O). MS, /z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95 , 143 100), 35 (65 , 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; , 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single cry tal of 5  was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was btained by recrystallization from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), an   single crystal of 28 was obt ined 
acenaphthequinone recrystallization from CH3OH (methanol). The singl -crystal X-ra  analys s 
were carried out on a Bruker D8 Ventur  diffract meter with Ph ton100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F ) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Se i-empirical absorpti n correcti ns were applied.  Ǻ 
Compound 5  (SB1184_HY): C13H9N3OS, Mr = 255.  g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr  405.42 g mol−1, y llow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflecti s (2θmax = 144.4°), 3575 ind pendent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, b = 23.3483 (9)
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H, H-thiazole). 13C-NMR (100 M z, DMSO-d6): δ = 14.0 , 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 1 4.56 (vinyl-CH), 1 0.79, 2.09, .36, .58, .7 , 33.70, 135.82 (PC-CH), 
138.17, 138.55, 138.9 , 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 1 5.62 (ester C=O). S m/z (%) = 447 (M+, 62), 306 (3 ), 153 (100), 135 (65), 1 6 ( 0). Anal. 
Calcd. For C25H25N3O3S (44 55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.1 ; H, 5.6 ; N, 9.45; S, 
.28. 
Ethyl 2-((Z) 3-Amino 2-(((E)-1-(1,4(1,4)-dibe zenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
yli ene)-4-oxo hiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-N R (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 z 33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m 6H, PC-H), 6.5  (s, 1H, PC-H), 6.72 ( , 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-N R (100 M z, DMSO-d6 : δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 1 5.46 (vi yl-CH), 131.8 , 132.18, 132.40, 132.60, 
132.73, 135.72, 34.86 (PC-CH), 138.27, 138.60, 13 .99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 ( ster C=O). MS, /z (%) = 462 (M+, 6), 307 (25), 
248 40 , 55 (27), 154 (95), 143 (10 , 135 (65 , 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 2.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray S ructure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5  was obtained by ecrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obta ned by crystallization from C2H5OH ( tha ol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 fr m CH3CN (acetonitrile), n  a single cryst l of 28 was obtained 
acenapht equinone ecrystalliz tion from CH3O  (methanol). The single-crystal X-ray analyses 
were carried ut on a Bruker D8 V nture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Meth ds (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used f r structure solution nd refinement was carried out using SHELXL-2014 
(f ll-matrix least-squares on F2) [59]. Hydroge  atoms were refined using a riding model (H (N, O) 
free). Semi-em irical absorption corrections were applied.  Ǻ 
Compound 5  (SB1184_HY): C13H9N3OS, Mr = 255.  g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, m noclini , space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0 37 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff  peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamid  methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr  40 .42 g mol−1, llow blocks, size 0.12 × 0.06 × 0.04 
mm, mon clinic, space group P21/n (n .14), a = 7 0 03 2 b 5 6 14 c  16.4943 (5) Ǻ, β = 
98. 17 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000)  84 , μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured r flections (2θmax = 144.4°), 3575 indepe d t reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H3 N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c  22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
isordered, disordered at ms refined isotropically. In th second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constrain s (EADP) and res raints (SADI) for th  refinement s well as a general RIGU restraint. 
, c = 23.3963 (9)
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine  
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1 , PC-H), 6.72 (s 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a singl  crystal f 8d wa  obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a single crystal of 2  was obtained 
acenaphthequinone recrystallization from CH3OH (methanol). The singl -crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detect r 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, or nge blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) , β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, α = 60.101 (2)◦, β = 84.894 (3)◦, γ = 84.516 (3)◦, V 6478.3 (5)
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1 , NH-thiazole). 1 C-NMR (100 Hz, D SO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.0  (PC-
CH2), 61.25 (O H2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 132.58, 132.70, 13 .70, 135.82 (PC-CH), 
138.17, 138.55, 8.9 , 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165. 2 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 10  (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5. 3; N, 9.39; S, 7.16. F und: C, 67.12; H, 5.6 ; N, 9. 5; S, 
7.28. 
Ethyl 2-((Z)-3-Amin -2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylid ne)-hydrazine- 
ylidene)- -oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals ( H3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH) 2924 (Ali- H), 1735, 720 (C ), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, P -CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vi yl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 5 .40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 1 5.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thi zole-C5), 159.17, 
166.02 (thiazole-C , C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5 67; N, 12.11; S, 6.93. Found: C, 65. 1; H, 5.75; N, 12. 6; S, 7.02. 
3. . Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a w s obtaine  by r crystallization from C2H5OH (ethanol), a single crystal 
of 7d was obt ined by recrystallizat on from C2H5OH (ethan l), a single crystal of 8  was obtained 
from C2H5OH ( thanol), 25 from CH3CN ( c tonitrile), and a single crys al of 28 was obtained 
acenaphth qui one recr stallizati n from CH3OH (methanol). Th  si gle-crystal X-ray analyses 
were car ied ut on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD detector 
at 123K using Cu-Kα r diation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squar s on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [ or 4468 I › 2σ (I)] 030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioa ide methanol solvate) [60]. 
Compound 7d (SB1 86_HY): C21H15N3O4S, Mr = 405.42 g ol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 indep ndent r fl ctions [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compou d 8d (SB1185_HY): C40H37N3O17 , Mr = 863.78 g mol−1, orange p at s, size 0.09 × 0.06 × 0.03 
mm, tri linic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = .43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered toms r fined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
3, Z 8, Dcalcd = 1.221 Mg m−3, F
(000) = 2552, µ (Cu-Kα) = 1.74 mm−1, T 123 K, 67389 measured reflections (2θmax = 14 .4◦), 24776
independent reflections [Rint = 0.067], 1485 parameters, 1254 restraints, R1 [for 16,926 I › 2σ (I)] = 0.115,
wR2 for all data) = 0.321, S 1.01, largest diff. peak and hole .33 e
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1H, N -thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14. 1, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl- ), 130.79, 132.09, 132.36, 132.58, 32.70, 33.70, 135.82 (PC-CH), 
138. 7, 1 8.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165. 2 (ester C=O). MS, m/z (%) = 447 (M+, 6 ), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447.55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; , 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C  
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 z), 2.33 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH ), 4.27 (q, 2H, OC 2, J = 7.2 Hz), 6.68 ( , 6 , PC-H), 6.57 ( , 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66,
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 1 5.72, 134.86 (PC- H), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C ), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (e t r C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. or C25H26N4O3S (462.56): C, 64.91; 
, 5.67; N, 12. 1; S, 6 93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02.
3.2. Single Crystal X-ray Structure Deter inati n of 5a, 7d, 8 , 5 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recryst llization from C2H5O  (ethanol), a single crystal f 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonit ile), and a single crystal of 28 was obtain d 
acenaphthequinone recrystallization from CH3OH (methanol). T e single-crystal X-ray analys s 
were carried out on a Bruker D8 Venture diffractometer with Photon100 or Photon II CPAD det cto  
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Meth ds (SHELXS [58]  Dual Sp ce Methods
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-e pirical absorption corrections were applied.  Ǻ 
Compound 5a (SB11 4_HY): C13H9N3OS, Mr 255.29 g mol−1, orange blocks, size .30 × 0.25 × 0.20 
m , monoclinic, space group P21/c (no. 4), a = 6.3 57 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236
eas re  reflections (2θmax = 144.2 °), 4510 indepe dent reflecti ns [Rin  = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (  all dat ) = 0.079, S = 1.06, largest diff. p ak and h le = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a poly rph of EBINOV (2-(2-oxoacena hthyle -1(2H)-yli ne) 
hydrazinec rbothioamide methan l solvate) [60]. 
Compound 7d (SB1 86_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independe t r flections [ int = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
−3/−0.79 e
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1H, N -thiazole). 13C- R (10  MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), .53  4.61, 34.75, 5.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132. 6, 132.5 , 132.70, 13 .70, 135. 2 (PC-CH), 
138. 7, 8.55, 138.96, 139.2  (P -C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, m/z (%) = 447 (M+, 6 ), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calc . For C25H2 N3O3S (447.55): C, 67.09; , 5.63; N, 9.39; S, 7.16. Found: C, 7.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dib nzen cyclohexap ane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)ac tate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 17 0 (CO 22 C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz 2.3  (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, O 2, J = 7.2 Hz), 6.68 m, 6H, PC- ), 6.57 (s, 1H, PC- ), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 ( 3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 13 .81, 132.18, 132.40, 132.60, 
132.73, 1 5.72, 134.86 PC- H), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (est r C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 15  (27), 154 (95), 143 (100), 135 (65), 106 (20). A al. Calcd. fo  C25H26N4O3S ( 62.56): C, 64.91; 
H, 5.67; N, 2.11; S, 6.93. Found: C, 65.01; H, 5.7 ; N, 12.16; S, 7.02. 
3.2. Singl Crystal X-ray Structure Determination of , 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recryst llization from H5OH (ethanol), a single cry tal of 8d was obt n d 
fro  C2H5OH ethanol), 25 from CH3CN (aceto itrile), and a single cryst l of 28 was obtained 
acenaphthequin ne recrystallization from CH3OH (metha o ). T e single-cryst  X-ray analyses 
were carried out on a Bruker D8 V ntur  diffractom ter with Phot n100 or Photo  II CPAD detector 
at 123  using Cu-Kα radiation (λ = 1.54178 Å). Direct Metho s (SHELXS [58] or Dual pac  Method  
(SHELXT [59]) wer  used for structur  solution a d refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refine  using a riding odel (H (N, O) 
free). emi-em irical absorption co rections w re applie .  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 55.29 g mo −1, orang blocks, size 0.30 × 0.25 × 0.2  
mm, monoclinic, pace group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 8.2558 ( ) Ǻ, c = 20.073  (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3 Z = 8, Dcalcd = 1.473 Mg m−3, F ( 0 ) = 1056, μ (Cu-Kα) = 2.4  mm−1, Τ = 123 K, 19236 
m asu ed reflections ( θmax = 144.2 °), 4510 independ nt reflectio s [Rint = 0.023], 343 paramet r , 6 
restraint , R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for ll data) = 0.079, S = 1.06, largest iff. peak and hole = 0.37 
e Ǻ−3/−0.31 e −3. It is a polymo ph of EBINOV (2-(2-oxoacenaphthyl n-1(2H)-ylidene) 
hydrazinecarbothio m de me hanol solvate) [60].
Compound 7d (SB1 86_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, m noclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.9 7 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
23 K, 18041 m asured reflections (2θmax = 144.4°), 3575 independ nt reflections [Rint = 0.024], 263 
arameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = .077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ− . 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mo −1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-  (no. 2), a = 12.8863 (5) Ǻ, b = 15.10 3 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104. 6  (2)°, V = 4000.  (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 rest aints, R1 [for 14,02  I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. p ak and hole = 1.52 e −3/−0.59 e Ǻ−3. In the 2nd molecule th  vinyl moiety is 
i , disordered atoms refined isotropically. In the second m lecule the oxac naphthylene 
moiety shows high Uij-v lues, probably disordere , but the disorder is not r solved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
−3. The compound
was refined as a two-component pseudo merohedral twin. A g n ral RIGU restraint is used for the
refinement due to the b d quality of the data. Two solvent molecules acetonitrile per asymmetric unit
disorder d, the disorder d at ms refined isotropically.
Compound 28 (SB1183_HY): C25H25N3O3S · CH3OH, Mr = 479.58 g mol−1, yellow plates, size 0.16 ×
0.14 × 0.02 mm, monoclinic, space group P21/c (no,.14), a = 19.5995 (5)
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 ( 3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-C ), 130.79, 132.09, 1 2.36, 132.58, 132.70, 33.70, 135.82 (PC- ), 
138.17, 138.55, 138.96, 39.22 (PC-C), 142.90 (thiazol -C5), 158.45, 65.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 65.62 (ester C=O). MS, m/z (%) = 447 (M+, 6 ), 306 (32), 5  (100), 135 (65), 106 (20). Anal. 
Calcd. F r C25H25N3O3S (447.55): C, 67.09; H, .63; N, 9.39; S, 7.16. Fo d: , 67.12; H, 5.66; N, 9.45; S, 
7.2 . 
Ethyl 2-((Z) 3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacycloh xaphane-12-yl)ethyli e e)-hydrazine- 
yliden )-4-oxothi zolidin-5-yl)acetate 9). Yield: ( .374 g, 81%); yellow cryst ls (CH3OH); m.p. 174–175 
°C. IR (KBr): ν  33 4 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 35, 1720 (CO), 1622 (C=N), 16 7 (Ar-C=C) 
cm−1. 1H-NMR (40  MHz, DMSO- 6): δ = 1.28 (t, 3H, CH3, J  7.2 z), 2.33 (s, 3H, CH3), 2. 2–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 s, 1H, PC-H), 6.7  (s, 1H, vinyl-
CH), 10.09 b, s, 2H, NH2). 13C-NMR (1 0 MHz, DMSO- 6): δ  14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 ( CH2), 115.46 (vinyl-CH), 131.81, 13 .18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cycl c-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. C lc . for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. ound: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A si gle crystal of 5a was obtained by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrystalliz tion from C2H5OH (ethanol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), and a si gle crystal of 28 was obtained 
ce aphthequinone recrystallization fro  CH3OH ( eth nol). Th  single-crystal X-ray analyses 
were carried out on a Bruker D8 Venture diffract met r with Phot n100 or P oton II CPAD det ctor 
at 23K using Cu-Kα radiati n (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) were used for structure so utio  and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. ydr gen atoms were refined using a riding model (H (N, O) 
free). Semi-em irical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
m, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 2 .0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) 3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.090  (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 easured r flecti ns (2θmax = 144.4°), 3575 indep n nt reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, b = 7.4181 (2)
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1 , N -t iazole). 13C-N R (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34. 3, 4.61, 34.75, 35.03 (PC-
C 2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 1 2.58, 1 2.70, 133.70, 1 5.82 (PC-CH), 
138.17, 138.55, 138.96, 13 .2  (PC-C), 142.90 (thiaz le-C5), 158.45, 165.27 (thiazole-C , C=N), 165.32 
(cyclic-C=O), 165. 2 (ester C=O). MS, m/z (%) = 4 7 (M+, 62), 306 (32), 153 ( 00), 135 (65), 106 (20). Anal. 
Calcd. For C2 H25N3O3S (44 . 5): C, 67.0 ; H, 5. 3; N, 9.39; S, 6. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibe z nac clohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-ox thiazoli in-5-yl) cetate 29). Yi ld: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali- H 35, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-N R (400 MHz, DMSO-d6): δ = 1.28 (t, H, CH3, J  7.2 Hz), . 3 (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2 , OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 ( , 1H, PC-H), 6.72 ( , 1H, vinyl-
C ), 10. 9 (b, s, 2H, H2). 13C-N R (1 0 MHz, DM O-d6): δ = 14.38 (CH3), 18.6  (CH3), 34.57, 34.66, 
34.76, 5.12, P -CH2), 54.40 (OCH3), 62.0 (OC 2), 115.46 (vinyl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 1 9.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). M , m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. fo  C25H 6N O3S (462.56): C, 6 .91; 
H 5 67; N, 12.11; S, 6 93. Found: C, 65.0 ; H 5 75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obt ined by recrystallization from C2H5OH (ethanol), a single crystal 
of 7d was obt ined by r crystallization from C2H5OH (ethanol), a single cryst l of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (ac tonitrile), and a single crystal of 28 was obtained 
ac aphthequinone recrystallization fr m CH3OH (methanol). The single-cr t l X-ray analyses 
were carri d out on a Bruker D8 Venture diffractometer wit  Photon 00 or Photon II CPAD detector 
at 123K using Cu-Kα radiation (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) we  us d for structure solution and ref eme t was carried out using SHELXL-2014 
(full-matrix least-squares n F2) [59]. Hydrog n atom  were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5  (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
m , monoclinic, space group P21/c (no.14), a = 6 33 7 2 b 18 2558 c = 20.0737 (7) Ǻ, β = 97.327 
(1 °, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independe t reflections [Rint = 0.023] 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
ydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 5.42 g mol−1, y llow blocks, size 0.12 × .06 × 0.04 
mm, mon clinic, space group P21/n (no.14) a  7.0903 (2) Ǻ, b = 15.691  (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independ  refl ctions [Rint = 0.024], 263 
par meters, R1 [for 34  I › 2σ I)] = 0.029, wR2 (for all d ta) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) , c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V  000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14, 20 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disor ered, disordered a oms refined isotropically. In the second molecule th  oxacenaphthylene 
moiety shows high Uij-values, p obably disor ered, but the disord r is not resolved. Use of 
constraint  (EADP) and restraints (SADI) for the refinem t as well as a general RIGU restraint. 
, c = 18.2170
(5)
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1H, N -thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 132.36, 1 2.58, 132.70, 133.70, 1 5.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158. 5, 165.27 (thiazole-C , C=N), 165.32 
(cyclic-C=O), 165. 2 (ester C=O). MS, m/z (%) = 447 (M+, 62), 306 (3 ), 153 (100), 5 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3S (447. 5): C, 67.09; H, 5.63; N, 9.39; S, 7. . Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crys als (CH3O ); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 17 0 (CO 62  (C=N 607 (Ar-C=C  
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), .33 (s, 3H, CH3 , 2 92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vinyl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.6  (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OC 2), 115.46 (vinyl-CH), 31.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17, 
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (ester C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 (40), 155 (27), 154 (95), 143 (100), 135 (65), 106 (20). Anal. Calcd. fo  C25H26N4O3S (462.56): C, 6 .91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single crystal of 5a was obtained by recrystallization fro  C2H5OH (eth nol), a single cryst l 
of 7d was obtained by recrystallization from C2H5OH (ethanol), a singl  crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN (ac tonitrile), and a single crystal of 28 was obtained 
ace aphthequinone recrystallization fr m CH3OH (metha ol). The single-cryst l X-ray analyses 
were carried out on a Bruker D8 Venture diffractometer wit  Photon 00 or Photon II CPAD det ctor 
at 123K using Cu-Kα radiatio  (λ = 1.54178 Å). Direct Methods (SHELXS [58] or Dual ace Methods 
(SHELXT [59]) were used for structure solution and refinement was carried out using SHELXL-2014 
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-empirical absorption corrections were applied.  Ǻ 
Compound 5  (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1, orange blocks, size 0.3  × 0.25 × 0.20 
m , monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 5.42 g mol−1, yellow blocks, size 0.12 × .06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b = 15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
par meters, R1 [for 3402 I › 2σ (I)] = 0.029, wR2 (for all data) = 0.077, S = 1.06, largest diff. peak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, s ze 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
, β = 112.833 (2)◦, V = 2441.04 (12
Molecules 2019, 24, x FOR PEER REV EW 15 of 19 
1H, NH-thiazole). 13C-NMR (100 M z, DMSO-d6): δ = 14.01, 18.36 (CH3), 34.53, 34.61, 34.75, 3 .03 (PC-
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 1 2.3 , 132.58, 132.70, 133.70, 135.82 (PC- ), 
138.17, 138.55, 138.96, 39.22 (PC-C), 142.90 (thiazole-C5), 1 8.45, 165.27 (thiazole-C2, C=N), 65. 2 
(cyclic-C O), 165.62 (ester =O). MS, m/z (%) = 447 (M+, 62), 306 (32), 153 (100), 135 (65), 106 (20). Anal. 
Calcd. For C25H25N3O3  (447 55): C, 67.09; H, 5.63; N, 9.39; S, 7.16. Found: C, 67.12; H, 5.66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzen cyclohexaphane 12-yl)ethyl dene)-hyd azine-
yliden )-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 8 %); y llow cry tals (CH3OH); m.p  174–175 
° . IR (KBr): ν = 3344 (NH), 31 0 Ar-CH), 92  (Ali-CH), 1735, 1720 (CO  62  (C=N 607 (A -C=C) 
cm−1. 1H-NMR (400 MHz, DMS -d6): δ  28 (t H, CH , J = 7.2 Hz), 2.3  ( , 3H, C 3), 2.92–3.04 (m,
8H, PC-CH2), 4.27 (q, 2H OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6. 7 (s, 1H, PC-H), 6.72 (s, 1H, vi yl-
H), 10.09 (b, s, 2H, NH2). 13C-NM  (100 MHz, DMSO-d6): δ = 14.38 (CH3), 18.62 (CH3), 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vi yl-CH), 131.81, 132.18, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 139.25 (PC-C), 143.56 (thiazole-C5), 159.17,
66.02 (thiazole-C2, C=N), 165.95 (cyclic-C O), 176.02 ( ster C=O). MS, m/z (%) = 462 (M+, 6), 307 (25), 
248 40 55 7 , 154 (95), 143 (100), 135 (65), 106 ( 0). Anal. Calcd. for C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Fo nd: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5a, 7d, 8d, 25 and 28 
A single cryst l f 5a was obtained by re rystalliz tion fr m C2H5OH (ethanol), a single crystal 
of 7d was obtained by recrysta lization from C2H5OH (e h ol), a single ryst l f 8  was obtained 
from C2H5OH (ethanol), 25 from CH3CN (acetonitrile), nd a single crystal of 28 was obtained 
acenaphthequinone crystallizatio  fr m CH3OH ( e anol). The singl -crystal X-ray analyses 
were car ied ut on a Bruker D8 Venture iffractomete  with Ph ton100 or Ph ton II CPAD detector 
at 123K using Cu-Kα ra iation (λ = 1. 4178 Å). Dir ct Methods (SHELXS [58] or Dual Space Methods 
(SHELXT [59]) w re used for structure s lution and refinement was carried out using SHELXL- 014 
(full-matrix least- quar s on F ) [59]. Hydrogen atoms were refined using a riding model (H (N, O) 
free). Semi-em irical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS Mr = 255.29 g mol−1, orange blocks, size 0.30 × 0.25 × 0.20 
mm, monoclinic, space group P21/c (no.14), a = 6.3357 (2) Ǻ, b = 18.2558 (7) Ǻ, c = 20.0737 (7) Ǻ, β = 97.327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg 3 F (000) = 1056, μ (Cu-Kα) = 2.42 mm−1, Τ = 123 K, 19236 
measured r fl ctions (2θmax = 144.2 °), 4510 independent r flections [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 ( or all data) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow bl cks, size 0.12 × 0.06 × 0.04 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) , b  15.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg −3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 180 1 meas red r fl ctio s (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)]  0. 29, wR2 (for ll d ta) = 0.077, S = 1.06, larg st diff. pe k nd 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, r ng  plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 ( o. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 11 3 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refin d iso ropically. In the second molecule the oxacenaphthylene 
moiety sh ws high Uij-values, probably disorder , but the disorder is not resolved. Use of 
constrain s (EADP) and restraint (SADI) for the refinement as well as a general RIGU restraint. 
3, Z = 4, Dcalcd .305 Mg m−3 F (000) = 1016, µ (Cu-Kα) =
1.49 mm−1, T = 123 K, 25915 m asured reflections (2θmax = 144.6◦), 4808 independent reflections [Rint
= 0.052], 3 5 parameters, two restraints, R1 [for 4146 I › 2σ (I)] = 0.064, wR (for all data) = 0.155, S =
.17, largest diff peak and hole = 0.46 e
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 1 .01, 18.36 (C 3), 34.53, 34.61, 34.75, 35.03 ( -
CH2), 61.25 (OCH2), 114.56 (vinyl-CH), 130.79, 132.09, 13 .36, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.96, 139.22 (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 165.32 
(cyclic-C=O), 165.62 (ester C=O). MS, /z (%) = 447 (M+, 62), 30  (32 ,  100), 135 65), 106 (20). An l.
Calcd. For C25H25N3O3S (447.55): C, 67.09; , 5.63; N, 9.39; S, 7.16. Found: C, 67.1 ; H, .66; N, 9. 5; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dibenzenacyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothiazolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 1720 (CO), 1622 (C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2. 3 (s, 3H, CH3), 2.92–3.04 (m,
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.68 (m, 6H, PC-H), 6.57 (s, 1H, PC-H), 6.72 (s, 1H, vi y -
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 14. 8 (CH3), 18.62 (CH3), 34.57, 34.66,
34.76, 35.12, (PC-CH2), 54.40 (OCH3), 62.0 (OCH2), 115.46 (vinyl-CH), 131.81 132. 8, 132.40, 132.60, 
132.73, 135.72, 134.86 (PC-CH), 138.27, 138.60, 138.99, 39.25 (PC-C), 143. 6 (thiazole-C5), 159.17,
166.02 (thiazole-C2, C=N), 165.95 (cyclic-C=O), 176.02 (este  C=O). MS, m/z (%) = 462 (M+ 6), 307 (25),
248 (40), 155 (27), 154 (95), 143 (100), 135 65), 106 (20). Anal. Calc . f r C25H26N4O3S (462.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray St ucture Determination of 5a, 7d, 8d, 25 and 8 
A single crystal of 5a was obtai ed by recrystallization from C2H5OH (eth nol), a s ngl  crystal 
of 7d was obtained by recrystallization from C2H5OH (eth nol), a single crystal of 8d was obtained 
from C2H5OH (ethanol), 25 from CH3CN ( cetonitr le), and  single crystal of 28 was obtain d 
acenaphthequinone recrystallizati n f om CH3OH (metha ol). The s gle-crystal X- y nalyses 
were carried out on a Bruker D8 Ventur d ffr ctometer with Phot n100 or Photon II CPAD detector 
at 123K using Cu-Kα radi tion λ = 1.54178 Å). Direct Meth  (SHELXS [58] or Dual Sp c  M thod  
(SHELXT [59]) were used fo  structure solution and refinement was carried out using SHELXL-2014 
(full- atrix least-squares on F2) [59]. Hydrogen atoms were refin d using a riding model (H (N, O) 
free). Se i-empirical absorption corrections were applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 255.29 g mol−1 o ange blocks, size 0.30 × 0.25 × 0.20
mm, monoclinic, space group P21/c (no.14), a = 6.3 57 (2) Ǻ, b = 18. 558 (7) Ǻ, c = 2 .0737 (7) Ǻ, β = 9 .327
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg m−3, F (000) = 1 56, μ (Cu- α) = 2.42 mm−1, Τ 23 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 independent reflectio s [ int = 0.023], 343 parameters, 6
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 ( or all dat ) = 0.079, S = 1.06, largest diff. peak and hole = 0.37 
e Ǻ−3/ 0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoac naphthylen-1(2H)-yli en ) 
hydrazinecarbothioamide methanol solvate) [60]. 
Compound 7d (SB1186_HY): C21H15N3O4S, Mr = 405.42 g mol−1, yellow blocks, size . 2 × 0.06 × . 4 
mm, monoclinic, space group P21/n (no.14), a = 7.0903 (2) Ǻ, b  5.6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 mm−1, Τ = 
123 K, 18041 measured reflections (2θmax = 144.4°), 3575 independent reflections [Rint = 0.024], 263 
parameters, R1 [for 3402 I › 2σ (I)] = 0.029, wR  (for all d ta) = 0.077, S = 1.06, largest diff. peak nd 
hole = 0.28 e −3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O17S, Mr = 863.78 g mol−1, orange plates, size 0.09 × 0.06 × 0.03 
mm, triclinic, space group P-1 (no. 2), a = 12.8863 (5) Ǻ, b = 15.1023 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104.460 (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 restraints, R1 [for 14,020 I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. peak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the vinyl moiety is 
disordered, disordered atoms refined isotropically. In the second molecule the oxacenaphthylene 
moiety shows high Uij-values, probably disordered, but the disorder is not resolved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as well as a general RIGU restraint. 
−3/−0.32 e
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1H, NH-thiazole). 13C-NMR (100 MHz, DMSO-d6): δ = 14.01 18 36 (CH3) 53 4 61, 34.75, 35.03 (PC-
CH2), 61.25 (OCH2), 1 4.56 (vinyl-CH), 130.79, 132.09, 1 2. 6, 132.58, 132.70, 133.70, 135.82 (PC-CH), 
138.17, 138.55, 138.9 , 139.2  (PC-C), 142.90 (thiazole-C5), 158.45, 165.27 (thiazole-C2, C=N), 65.32 
(cyclic- =O), 165.6 (ester C=O). MS, m/z %) = 447 (M+, 62), 306 (3 ) 5 ( 00), 135 (65), 106 (20). Anal. 
Calcd. For C25H2 N3O3S (447.55 : C, 67.09; , .63; N, 9. 9; S 7. 6. Fo nd: C, 7.1 ; H, 5 66; N, 9.45; S, 
7.28. 
Ethyl 2-((Z)-3-Amino-2-(((E)-1-(1,4(1,4)-dib nzen cyclohexaphane-12-yl)ethylidene)-hydrazine- 
ylidene)-4-oxothi zolidin-5-yl)acetate (29). Yield: (0.374 g, 81%); yellow crystals (CH3OH); m.p. 174–175 
°C. IR (KBr): ν = 3344 (NH), 3100 (Ar-CH), 2924 (Ali-CH), 1735, 17 0 (CO 22 C=N), 1607 (Ar-C=C) 
cm−1. 1H-NMR (400 MHz, DMSO-d6): δ = 1.28 (t, 3H, CH3, J = 7.2 Hz), 2.  (s, 3H, CH3), 2.92–3.04 (m, 
8H, PC-CH2), 4.27 (q, 2H, OCH2, J = 7.2 Hz), 6.6  (m, 6H, PC- ), 6. 7 (s 1H, PC- ), 6.72 (s, 1H, vi yl-
CH), 10.09 (b, s, 2H, NH2). 13C-NMR (100 MHz, DMSO-d6): δ = 4 38 ( 3), 18.62 (CH3 34.57, 34.66, 
34.76, 35.12, (PC-CH2), 54.40 (OCH3) 62.0 (OCH2), 15.46 (vinyl-CH), 131.81, 132.18, 132 0, 132.60, 
132.73, 135.72, 13 .86 (PC-CH) 38.27, 138.60, 138.99, 139.2  (PC-C), 143.56 (thiazole-C5), 159.1 ,
166.02 (thi zole-C2, C=N), 165.95 (cycl c-C O), 176.02 (ester C O). MS, /z %) 462 (M+, 6), 307 (25),
248 (40), 15  (27), 154 (95), 143 (1 0), 13  (65), 1 6 (20). Anal. Calcd. for C25H26N4O3S ( 62.56): C, 64.91; 
H, 5.67; N, 12.11; S, 6.93. Found: C, 65.01; H, 5.75; N, 12.16; S, 7.02. 
3.2. Single Crystal X-ray Structure Determination of 5 , 7d, 8d, 25 nd 28 
A single crystal of 5a was obtai ed by recrystallization from C2H5OH (ethanol), a single cry tal 
of 7d was obtained by recrystallization f om C2H5OH (eth nol), a single c ystal of 8d was btained 
from C2H5OH (ethanol), 25 from CH3CN (acetonit il ), and a single crystal f 8 was obtained 
acenaphthequinone rec ystalliz tion fr  CH3OH (m tha o ). Th  s ng -crys l X-ray nalyses 
were carried out on a Bruker D8 Ventur  d ffr ctome er wit  P ot n100  Phot n II CPAD detector 
at 12  using Cu- α radiation (λ = 1.54178 Å). Direc  Methods (SHELXS [58] or Dual Space M tho s 
(SHELXT [59]) were used for structur  solution a d refinement w s carried out using SHELXL-2014
(full-matrix least-squares on F2) [59]. Hydrogen atoms were refine  using a riding model (H (N, O) 
free). Semi-em irical absorption co rections w re applied.  Ǻ 
Compound 5a (SB1184_HY): C13H9N3OS, Mr = 55.29 g mo −1, rang blocks, size 0.30 × 0 25 × 0.20 
mm, monoclinic, sp ce group P21/c (no.1 ), a = 6.3 57 (2) Ǻ, b = 18. 558 ( ) Ǻ, = 20.07 (7) Ǻ, β = 9 .327 
(1)°, V = 2302.83 (14) Ǻ3, Z = 8, Dcalcd = 1.473 Mg −3, F (000) = 1056, μ (Cu-Kα) = 2.4  mm−1, Τ = 12 K, 19236 
measured reflections (2θmax = 144.2 °), 4510 ind enden eflection  [Rint = 0.023], 343 parameters, 6 
restraints, R1 [for 4468 I › 2σ (I)] = 0.030, wR2 (for all data) = 0.079, S = 1.06, larg st iff. peak and hole = 0.37 
e Ǻ−3/−0.31 e Ǻ−3. It is a polymorph of EBINOV (2-(2-oxoacenaphthylen-1(2H)-ylidene) 
hydrazinecarbothio mide me hanol solvate) [60]. 
Compound 7d (SB1 86_HY): C21H15N3O S, Mr = 405.42 g mol−1, yellow blocks, size .12 × 0.06 × . 4 
m monoclinic, space gr up P21/n (no.14), a = 7.0903 ( ) Ǻ, b  .6914 (5) Ǻ, c = 16.4943 (5) Ǻ, β = 
98.917 (1)°, V = 1812.92 (9) Ǻ3, Z = 4, Dcalcd = 1.485 Mg m−3, F (000) = 840, μ (Cu-Kα) = 1.90 m −1, Τ = 
123 K, 18041 m asured reflections (2θmax = 144.4°), 3575 in ependent reflections [Rint = 0.024], 263 
parameters, R1 [f r 3402 I › 2σ (I)] = 0.029, wR2 (for all d ta) = 0.077, S = 1.06, largest diff. p ak and 
hole = 0.28 e Ǻ−3/−0.30 e Ǻ−3. 
Compound 8d (SB1185_HY): C40H37N3O1 S, Mr = 863.78 g mo −1, orange plates, size . 9 × 0.06 × 0.03 
mm, triclinic, space group P-  (no. 2), a = 12.8863 (5) Ǻ, b = 15.10 3 (6) Ǻ, c = 22.3027 (8) Ǻ, α = 100.800 
(2)°, β = 100.850 (2)°, γ = 104. 6  (2)°, V = 4000.4 (3) Ǻ3, Z = 4, Dcalcd = 1.434 Mg m−3, F (000) = 1800, μ (Cu-
Kα) = 1.43 mm−1, Τ = 123 K, 71781 measured reflections (2θmax = 144.4°), 15705 independent reflections 
[Rint = 0.039], 1113 parameters, 986 rest aints, R1 [for 14,02  I › 2σ (I)] = 0.059, wR2 (for all data) = 0.148, S 
= 1.10, largest diff. p ak and hole = 1.52 e Ǻ−3/−0.59 e Ǻ−3. In the 2nd molecule the v nyl moiety is 
, disordered atoms ref ned isotropically. In the second m lecule t e oxac naphthylene 
moiety shows high Uij-values, probably disordere , but the disorder is not r s lved. Use of 
constraints (EADP) and restraints (SADI) for the refinement as wel as a general RIGU restraint. 
−3.
CCDC 1937480 (5a–sb1184_hy), 1937481 (7d–sb1186_hy), 1937482 (8d–sb1185_hy), 1937483
(25–sb1014_hy) an 1937484 (28–sb1183_hy) cont in the Supplementary crystallographic data for this
pa er. T ese data can be obtained fre of charg from The Cambridge Crystallographic Data Centre
via www.ccdc.cam.ac.uk/data_request/cif (details in Supplementary Materials).
4. Conclusions
In conclusi n, we prepared va ious derivatives o thiaz lodinone erive by ace aphthequi on
and [2.2]paracyclophane. We re able here t pr ve the structures f t e obtained products via X-ray
structure analysis. We could also, for the first time, get the X-ray structure analysis of the tetramer
form resulting from DMAD.
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